BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Abnet CC, Arnold M, Wei WQ. Epidemiology of Esophageal Squamous Cell Carcinoma. Gastroenterology. 2018;154:360-373. [PMID: 28823862 DOI: 10.1053/j.gastro.2017.08.023] [Cited by in Crossref: 355] [Cited by in F6Publishing: 371] [Article Influence: 71.0] [Reference Citation Analysis]
Number Citing Articles
1 Zagari RM, Marasco G, Tassi V, Ferretti S, Lugaresi M, Fortunato F, Bazzoli F, Mattioli S. Risk of Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus in Patients With Achalasia: A Long-Term Prospective Cohort Study in Italy. Am J Gastroenterol 2021;116:289-95. [DOI: 10.14309/ajg.0000000000000955] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
2 Ye J, Zhang L, Li Z, Lin R, Song Y, Ni H, Gou X, Xie R. High Expression of MDM2 and the p53 Protein is Predictive Biomarkers for Poor Prognosis of Oesophageal Squamous Cell Carcinoma. Cancer Manag Res 2021;13:2733-44. [PMID: 33790647 DOI: 10.2147/CMAR.S280326] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Liang Z, Zhao B, Hou J, Zheng J, Xin G. CircRNA circ-OGDH (hsa_circ_0003340) Acts as a ceRNA to Regulate Glutamine Metabolism and Esophageal Squamous Cell Carcinoma Progression by the miR-615-5p/PDX1 Axis. Cancer Manag Res 2021;13:3041-53. [PMID: 33854374 DOI: 10.2147/CMAR.S290088] [Reference Citation Analysis]
4 Yang H, Hu B. Early gastrointestinal cancer: The application of artificial intelligence. Artif Intell Gastrointest Endosc 2021; 2(4): 185-197 [DOI: 10.37126/aige.v2.i4.185] [Reference Citation Analysis]
5 Kwak AW, Lee MH, Yoon G, Cho SS, Choi JS, Chae JI, Shim JH. Deoxypodophyllotoxin, a Lignan from Anthriscus sylvestris, Induces Apoptosis and Cell Cycle Arrest by Inhibiting the EGFR Signaling Pathways in Esophageal Squamous Cell Carcinoma Cells. Int J Mol Sci 2020;21:E6854. [PMID: 32961992 DOI: 10.3390/ijms21186854] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Wu IC, Wang YK, Chen YH, Wu CC, Wu MC, Chen WC, Wang WL, Lin HS, Chen CC, Chou SH, Liu YP, Wu MT. High Serum Elafin Prediction of Poor Prognosis of Locoregional Esophageal Squamous Cell Carcinoma. Cancers (Basel) 2021;13:3082. [PMID: 34205756 DOI: 10.3390/cancers13123082] [Reference Citation Analysis]
7 Yao F, Yu J, He Y, Liu J, Li H, Liu Q, Long H, Wu Q. Primary impact of Gli1 on radioresistance in esophageal cancer. Oncol Lett 2019;18:4825-33. [PMID: 31611993 DOI: 10.3892/ol.2019.10837] [Reference Citation Analysis]
8 Meng RY, Jin H, Nguyen TV, Chai OH, Park BH, Kim SM. Ursolic Acid Accelerates Paclitaxel-Induced Cell Death in Esophageal Cancer Cells by Suppressing Akt/FOXM1 Signaling Cascade. Int J Mol Sci 2021;22:11486. [PMID: 34768915 DOI: 10.3390/ijms222111486] [Reference Citation Analysis]
9 Li Y, Du Q, Wei X, Guo Z, Lei T, Li Y, Han D, Wu X, Zhang K, Zhang T, Chen X, Dong J, Zhang B, Wei H, Zhang W, Pang Q, Wang P. A Clinical Scoring Model to Predict the Effect of Induction Chemotherapy With Definitive Concurrent Chemoradiotherapy on Esophageal Squamous Cell Carcinoma Prognosis. Front Oncol 2021;11:703074. [PMID: 34912702 DOI: 10.3389/fonc.2021.703074] [Reference Citation Analysis]
10 Feng Z, Li X, Qiu M, Luo R, Lin J, Liu B. LncRNA EGFR-AS1 Upregulates ROCK1 by Sponging miR-145 to Promote Esophageal Squamous Cell Carcinoma Cell Invasion and Migration. Cancer Biother Radiopharm 2020;35:66-71. [PMID: 31702393 DOI: 10.1089/cbr.2019.2926] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
11 Zheng B, Wu Z, Xue S, Chen H, Zhang S, Zeng T, Xu G, Wu W, Zheng W, Chen C. hsa_circRNA_100873 upregulation is associated with increased lymphatic metastasis of esophageal squamous cell carcinoma. Oncol Lett 2019;18:6836-44. [PMID: 31788127 DOI: 10.3892/ol.2019.11003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
12 Yu F, Wu W, Liang M, Huang Y, Chen C. Prognostic Significance of Rab27A and Rab27B Expression in Esophageal Squamous Cell Cancer. Cancer Manag Res 2020;12:6353-61. [PMID: 32801878 DOI: 10.2147/CMAR.S258940] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Liu W, Miao C, Zhang S, Liu Y, Niu X, Xi Y, Guo W, Chu J, Lin A, Liu H, Yang X, Chen X, Zhong C, Ma Y, Wang Y, Zhu S, Liu S, Tan W, Lin D, Wu C. VAV2 is required for DNA repair and implicated in cancer radiotherapy resistance. Signal Transduct Target Ther 2021;6:322. [PMID: 34462423 DOI: 10.1038/s41392-021-00735-9] [Reference Citation Analysis]
14 Ykema BLM, Hoefnagel SJM, Rigter LS, Kodach LL, Meijer GA, van Leeuwen FE, Khan HN, Snaebjornsson P, Aleman BMP, Broeks A, Meijer SL, Wang KK, Carvalho B, Krishnadath KK, van Leerdam ME; GIOCA-OES. Gene expression profiles of esophageal squamous cell cancers in Hodgkin lymphoma survivors versus sporadic cases. PLoS One 2020;15:e0243178. [PMID: 33347497 DOI: 10.1371/journal.pone.0243178] [Reference Citation Analysis]
15 Sheikh M, Poustchi H, Pourshams A, Etemadi A, Islami F, Khoshnia M, Gharavi A, Hashemian M, Roshandel G, Khademi H, Zahedi M, Abedi-Ardekani B, Boffetta P, Kamangar F, Dawsey SM, Pharaoh PD, Abnet CC, Day NE, Brennan P, Malekzadeh R. Individual and Combined Effects of Environmental Risk Factors for Esophageal Cancer Based on Results From the Golestan Cohort Study. Gastroenterology 2019;156:1416-27. [PMID: 30611753 DOI: 10.1053/j.gastro.2018.12.024] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 15.0] [Reference Citation Analysis]
16 Sheikh M, Brennan P, Malekzadeh R. Reply. Gastroenterology 2019;157:897-8. [PMID: 31310740 DOI: 10.1053/j.gastro.2019.07.016] [Reference Citation Analysis]
17 Halajzadeh J, Dana PM, Asemi Z, Mansournia MA, Yousefi B. An insight into the roles of piRNAs and PIWI proteins in the diagnosis and pathogenesis of oral, esophageal, and gastric cancer. Pathol Res Pract 2020;216:153112. [PMID: 32853949 DOI: 10.1016/j.prp.2020.153112] [Reference Citation Analysis]
18 Zeng RJ, Zheng CW, Gu JE, Zhang HX, Xie L, Xu LY, Li EM. RAC1 inhibition reverses cisplatin resistance in esophageal squamous cell carcinoma and induces downregulation of glycolytic enzymes. Mol Oncol 2019;13:2010-30. [PMID: 31314174 DOI: 10.1002/1878-0261.12548] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
19 Moaven O, Wang TN. Combined Modality Therapy for Management of Esophageal Cancer: Current Approach Based on Experiences from East and West. Surg Clin North Am 2019;99:479-99. [PMID: 31047037 DOI: 10.1016/j.suc.2019.02.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
20 Yi H, Duan H, Shi W, Liu Z, Liu Y. DEK overexpression is predictive of poor prognosis in esophageal squamous cell carcinoma. Arch Med Sci 2021;17:135-41. [PMID: 33488866 DOI: 10.5114/aoms.2019.84210] [Reference Citation Analysis]
21 Wang Y, Jiang Z, Xu C, Wang H, Tan L, Su J, Wang X, Jiang D, Hou Y, Song Q. Increased MET gene copy number negatively affects the survival of esophageal squamous cell carcinoma patients. BMC Cancer 2019;19:240. [PMID: 30885149 DOI: 10.1186/s12885-019-5450-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Chen Y, Wang J, Zhou H, Huang Z, Qian L, Shi W. Identification of Prognostic Risk Model Based on DNA Methylation-Driven Genes in Esophageal Adenocarcinoma. Biomed Res Int 2021;2021:6628391. [PMID: 34222478 DOI: 10.1155/2021/6628391] [Reference Citation Analysis]
23 Shen Q, Shang B, Jiang B, Wang Y, Wang Z, Chen G. Overexpression of JAB1 promotes malignant behavior and predicts poor prognosis in esophageal squamous cell carcinoma. Thorac Cancer 2020;11:973-82. [PMID: 32064781 DOI: 10.1111/1759-7714.13350] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
24 Liu Q, Zheng S, Chen Y, Liu T, Han X, Zhang X, Shen T, Lu X. TGF-β1-Induced Upregulation of MALAT1 Promotes Kazakh's Esophageal Squamous Cell Carcinoma Invasion by EMT. J Cancer 2020;11:6892-901. [PMID: 33123280 DOI: 10.7150/jca.48426] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Zheng C, Wang J, Xie S. P2RX7 Gene rs1718125 Polymorphism is Related with Postoperative Pain and Fentanyl Intake in Esophageal Cancer Patients. Pharmgenomics Pers Med 2020;13:585-9. [PMID: 33209050 DOI: 10.2147/PGPM.S252798] [Reference Citation Analysis]
26 Yang W, Chen CH, Jia M, Xing X, Gao L, Tsai HT, Zhang Z, Liu Z, Zeng B, Yeung SJ, Lee MH, Cheng C. Tumor-Associated Microbiota in Esophageal Squamous Cell Carcinoma. Front Cell Dev Biol 2021;9:641270. [PMID: 33681225 DOI: 10.3389/fcell.2021.641270] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
27 Yi L, Huang P, Zou X, Guo L, Gu Y, Wen C, Wu G. Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer. Pharmacol Res 2020;161:105144. [PMID: 32810627 DOI: 10.1016/j.phrs.2020.105144] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
28 Yano Y, Abnet CC, Poustchi H, Roshandel G, Pourshams A, Islami F, Khoshnia M, Amiriani T, Norouzi A, Kamangar F, Boffetta P, Brennan P, Dawsey SM, Vogtmann E, Malekzadeh R, Etemadi A. Oral Health and Risk of Upper Gastrointestinal Cancers in a Large Prospective Study from a High-risk Region: Golestan Cohort Study. Cancer Prev Res (Phila) 2021;14:709-18. [PMID: 33731409 DOI: 10.1158/1940-6207.CAPR-20-0577] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
29 Chen WC, Bye H, Matejcic M, Amar A, Govender D, Khew YW, Beynon V, Kerr R, Singh E, Prescott NJ, Lewis CM, Babb de Villiers C, Parker MI, Mathew CG. Association of genetic variants in CHEK2 with oesophageal squamous cell carcinoma in the South African Black population. Carcinogenesis 2019;40:513-20. [PMID: 30753320 DOI: 10.1093/carcin/bgz026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
30 Meng L, Zheng Y, Liu S, Ju Y, Ren S, Sang Y, Zhu Y, Gu L, Liu F, Zhao Y, Zhang X, Sang M. ZEB1 represses biogenesis of circ-DOCK5 to facilitate metastasis in esophageal squamous cell carcinoma via a positive feedback loop with TGF-β. Cancer Lett 2021;519:117-29. [PMID: 34216686 DOI: 10.1016/j.canlet.2021.06.026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Pan F, Xu X, Zhang LL, Luo HJ, Chen Y, Long L, Wang X, Zhuang PT, Li EM, Xu LY. Dietary riboflavin deficiency induces genomic instability of esophageal squamous cells that is associated with gut microbiota dysbiosis in rats. Food Funct 2020;11:10070-83. [PMID: 33135706 DOI: 10.1039/d0fo01944e] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
32 Lin CC, Doi T, Muro K, Hou MM, Esaki T, Hara H, Chung HC, Helwig C, Dussault I, Osada M, Kondo S. Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGFβ and PD-L1, in Patients with Esophageal Squamous Cell Carcinoma: Results from a Phase 1 Cohort in Asia. Target Oncol 2021;16:447-59. [PMID: 33840050 DOI: 10.1007/s11523-021-00810-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 Arnold M, Abnet CC, Neale RE, Vignat J, Giovannucci EL, McGlynn KA, Bray F. Global Burden of 5 Major Types of Gastrointestinal Cancer. Gastroenterology 2020; 159: 335-349. e15. [PMID: 32247694 DOI: 10.1053/j.gastro.2020.02.068] [Cited by in Crossref: 123] [Cited by in F6Publishing: 123] [Article Influence: 61.5] [Reference Citation Analysis]
34 Bednarz-Misa I, Fortuna P, Fleszar MG, Lewandowski Ł, Diakowska D, Rosińczuk J, Krzystek-Korpacka M. Esophageal Squamous Cell Carcinoma Is Accompanied by Local and Systemic Changes in L-arginine/NO Pathway. Int J Mol Sci 2020;21:E6282. [PMID: 32872669 DOI: 10.3390/ijms21176282] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
35 Meindl-Beinker NM, Betge J, Gutting T, Burgermeister E, Belle S, Zhan T, Schulte N, Maenz M, Ebert MP, Haertel N. A multicenter open-label phase II trial to evaluate nivolumab and ipilimumab for 2nd line therapy in elderly patients with advanced esophageal squamous cell cancer (RAMONA). BMC Cancer 2019;19:231. [PMID: 30871493 DOI: 10.1186/s12885-019-5446-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
36 Zhao Y, Zhang Q, Liu H, Wang N, Zhang X, Yang S. lncRNA PART1, manipulated by transcriptional factor FOXP2, suppresses proliferation and invasion in ESCC by regulating the miR‑18a‑5p/SOX6 signaling axis. Oncol Rep 2021;45:1118-32. [PMID: 33432363 DOI: 10.3892/or.2021.7931] [Reference Citation Analysis]
37 Pan F, Luo HJ, Wu ZY, Chen SZ, Wang X, Yu SX, Wang JM, Lin SY, Cai ZY, Gao YL, Zhuang PT, Xu LY, Li EM. Decreased plasma riboflavin is associated with poor prognosis, invasion, and metastasis in esophageal squamous cell carcinoma. Eur J Clin Nutr 2020;74:1149-56. [PMID: 32060383 DOI: 10.1038/s41430-020-0585-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
38 Luebeck GE, Vaughan TL, Curtius K, Hazelton WD. Modeling historic incidence trends implies early field cancerization in esophageal squamous cell carcinoma. PLoS Comput Biol 2021;17:e1008961. [PMID: 33939693 DOI: 10.1371/journal.pcbi.1008961] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Shaverdashvili K, Padlo J, Weinblatt D, Jia Y, Jiang W, Rao D, Laczkó D, Whelan KA, Lynch JP, Muir AB, Katz JP. KLF4 activates NFκB signaling and esophageal epithelial inflammation via the Rho-related GTP-binding protein RHOF. PLoS One 2019;14:e0215746. [PMID: 30998758 DOI: 10.1371/journal.pone.0215746] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
40 Ikeda G, Yamamoto S, Kato K. The safety of current treatment options for advanced esophageal cancer after first-line chemotherapy. Expert Opin Drug Saf 2021;:1-11. [PMID: 34263677 DOI: 10.1080/14740338.2021.1955100] [Reference Citation Analysis]
41 Hashemian M, Murphy G, Etemadi A, Poustchi H, Sharafkhah M, Kamangar F, Pourshams A, Malekshah AF, Khoshnia M, Gharavi A, Hekmatdoost A, Brennan PJ, Boffetta P, Dawsey SM, Abnet CC, Malekzadeh R. Nut consumption and the risk of oesophageal squamous cell carcinoma in the Golestan Cohort Study. Br J Cancer 2018;119:176-81. [PMID: 29950612 DOI: 10.1038/s41416-018-0148-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
42 Zhao F, Su JF, Lun SM, Hou YJ, Duan LJ, Wang NC, Shen FF, Zhang YW, Gao ZW, Li J, Du XJ, Zhou FY. Association between polymorphisms in the CYP1A1, CYP2E1 and GSTM1 genes, and smoking, alcohol and upper digestive tract carcinomas in a high-incidence area of northern China. Oncol Lett 2019;18:1267-77. [PMID: 31423187 DOI: 10.3892/ol.2019.10455] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
43 Inoue M, Shimizu Y, Ishikawa M, Abiko S, Shimoda Y, Tanaka I, Kinowaki S, Ono M, Yamamoto K, Ono S, Sakamoto N. Relationships of early esophageal cancer with human papillomavirus and alcohol metabolism. World J Gastroenterol 2020; 26(39): 6047-6056 [PMID: 33132654 DOI: 10.3748/wjg.v26.i39.6047] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Parker RK, Mwachiro MM, Topazian HM, Davis R, Nyanga AF, O'Connor Z, Burgert SL, Topazian MD. Gastrointestinal endoscopy experience of surgical trainees throughout rural Africa. Surg Endosc 2020. [PMID: 33258037 DOI: 10.1007/s00464-020-08174-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
45 Russi M, Marson D, Fermeglia A, Aulic S, Fermeglia M, Laurini E, Pricl S. The fellowship of the RING: BRCA1, its partner BARD1 and their liaison in DNA repair and cancer. Pharmacol Ther 2021;:108009. [PMID: 34619284 DOI: 10.1016/j.pharmthera.2021.108009] [Reference Citation Analysis]
46 Guan X, Liu C, Zhou T, Ma Z, Zhang C, Wang B, Yao Y, Fan X, Li Z, Zhang Y. Survival and prognostic factors of patients with esophageal fistula in advanced esophageal squamous cell carcinoma. Biosci Rep 2020;40:BSR20193379. [PMID: 31894852 DOI: 10.1042/BSR20193379] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
47 Yang F, Fu Y, Kumar A, Chen M, Si L, Rojanasarot S. Cost-effectiveness analysis of camrelizumab in the second-line treatment for advanced or metastatic esophageal squamous cell carcinoma in China. Ann Transl Med 2021;9:1226. [PMID: 34532363 DOI: 10.21037/atm-21-1803] [Reference Citation Analysis]
48 Zhou Q, Zhang Z, Long S, Li W, Wang B, Liang N. Opioids in cancer: The κ‑opioid receptor (Review). Mol Med Rep 2022;25:44. [PMID: 34878160 DOI: 10.3892/mmr.2021.12560] [Reference Citation Analysis]
49 Yao L, Zhong X, Huang G, Ma Q, Xu L, Xiao H, Guo X. Investigation on the Potential Correlation Between TP53 and Esophageal Cancer. Front Cell Dev Biol 2021;9:730337. [PMID: 34778250 DOI: 10.3389/fcell.2021.730337] [Reference Citation Analysis]
50 Zhang C, Zhang G, Sun N, Zhang Z, Xue L, Zhang Z, Yang H, Luo Y, Zheng X, Zhang Y, Yuan Y, Lei R, Yang Z, Zheng B, Wang L, Che Y, Wang F, Wang S, Gao S, Xue Q, Zhang Y, He J. An individualized immune signature of pretreatment biopsies predicts pathological complete response to neoadjuvant chemoradiotherapy and outcomes in patients with esophageal squamous cell carcinoma. Signal Transduct Target Ther 2020;5:182. [PMID: 32883946 DOI: 10.1038/s41392-020-00221-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
51 Noguera E, Sorribas M, Admella V, Biondo S. Oral health and gastrointestinal neoplasia: Narrative review. Cir Esp 2021:S0009-739X(21)00178-0. [PMID: 34144811 DOI: 10.1016/j.ciresp.2021.05.002] [Reference Citation Analysis]
52 Zhao J, Lei J, Yu J, Zhang C, Song X, Zhang N, Wang Y, Zhang S. Clinical efficacy and safety of apatinib combined with S-1 in advanced esophageal squamous cell carcinoma. Invest New Drugs 2020;38:500-6. [PMID: 31650447 DOI: 10.1007/s10637-019-00866-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
53 Huang Z, Zhou B, Li Z, Liu C, Zheng C, Zeng R, Hong C, Xu L, Li E, Peng Y, Xu Y. Serum interleukin-8 as a potential diagnostic biomarker in esophageal squamous cell carcinoma. Cancer Biomark 2020;29:139-49. [PMID: 32623391 DOI: 10.3233/CBM-201687] [Reference Citation Analysis]
54 Tian J, Zuo C, Liu G, Che P, Li G, Li X, Chen H. Cumulative evidence for the relationship between body mass index and the risk of esophageal cancer: An updated meta-analysis with evidence from 25 observational studies. J Gastroenterol Hepatol 2020;35:730-43. [PMID: 31733067 DOI: 10.1111/jgh.14917] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
55 Chen Q, Li J, Yang X, Ma J, Gong F, Liu Y. Prdx1 promotes the loss of primary cilia in esophageal squamous cell carcinoma. BMC Cancer 2020;20:372. [PMID: 32357862 DOI: 10.1186/s12885-020-06898-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
56 Guan H, Liu J, Lv P, Zhou L, Zhang J, Cao W. MicroRNA‑590 inhibits migration, invasion and epithelial‑to‑mesenchymal transition of esophageal squamous cell carcinoma by targeting low‑density lipoprotein receptor‑related protein 6. Oncol Rep 2020;44:1385-92. [PMID: 32945478 DOI: 10.3892/or.2020.7692] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
57 Zhao T, Hu Y, Zang T. DRACP: a novel method for identification of anticancer peptides. BMC Bioinformatics 2020;21:559. [PMID: 33323099 DOI: 10.1186/s12859-020-03812-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
58 Liu Q, He J, Zhou X, Han M, Li J, Liu C, Yuan H. ACP-5862 suppresses esophageal squamous cell carcinoma growth through inducing apoptosis via activation of endoplasmic reticulum stress and ROS production. Biochem Biophys Res Commun 2021;534:995-1002. [PMID: 33168189 DOI: 10.1016/j.bbrc.2020.10.052] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
59 Kuriyama K, Higuchi T, Yokobori T, Saito H, Yoshida T, Hara K, Suzuki S, Sakai M, Sohda M, Higuchi T, Tsushima Y, Asao T, Kaira K, Kuwano H, Shirabe K, Saeki H. Uptake of positron emission tomography tracers reflects the tumor immune status in esophageal squamous cell carcinoma. Cancer Sci 2020;111:1969-78. [PMID: 32302443 DOI: 10.1111/cas.14421] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
60 Fujikawa M, Koma YI, Hosono M, Urakawa N, Tanigawa K, Shimizu M, Kodama T, Sakamoto H, Nishio M, Shigeoka M, Kakeji Y, Yokozaki H. Chemokine (C-C Motif) Ligand 1 Derived from Tumor-Associated Macrophages Contributes to Esophageal Squamous Cell Carcinoma Progression via CCR8-Mediated Akt/Proline-Rich Akt Substrate of 40 kDa/Mammalian Target of Rapamycin Pathway. Am J Pathol 2021;191:686-703. [PMID: 33460563 DOI: 10.1016/j.ajpath.2021.01.004] [Reference Citation Analysis]
61 Li D, Li D, Meng L, Liu J, Huang C, Sun H. LncRNA NLIPMT Inhibits Tumorigenesis in Esophageal Squamous-Cell Carcinomas by Regulating miR-320/Survivin Axis. Cancer Manag Res 2020;12:12603-12. [PMID: 33324105 DOI: 10.2147/CMAR.S253452] [Reference Citation Analysis]
62 Qiu MJ, Yang SL, Wang MM, Li YN, Jiang X, Huang ZZ, Xiong ZF. Prognostic evaluation of esophageal cancer patients with stages I-III. Aging (Albany NY) 2020;12:14736-53. [PMID: 32701062 DOI: 10.18632/aging.103532] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
63 D'Souza SM, Houston K, Keenan L, Yoo BS, Parekh PJ, Johnson DA. Role of microbial dysbiosis in the pathogenesis of esophageal mucosal disease: A paradigm shift from acid to bacteria? World J Gastroenterol 2021; 27(18): 2054-2072 [PMID: 34025064 DOI: 10.3748/wjg.v27.i18.2054] [Reference Citation Analysis]
64 Wang P, Chen Y, Long Q, Li Q, Tian J, Liu T, Wu Y, Ding Z. Increased coexpression of PD-L1 and TIM3/TIGIT is associated with poor overall survival of patients with esophageal squamous cell carcinoma. J Immunother Cancer 2021;9:e002836. [PMID: 34625514 DOI: 10.1136/jitc-2021-002836] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Chen R, Zheng R, Zhou J, Li M, Shao D, Li X, Wang S, Wei W. Risk Prediction Model for Esophageal Cancer Among General Population: A Systematic Review. Front Public Health 2021;9:680967. [PMID: 34926362 DOI: 10.3389/fpubh.2021.680967] [Reference Citation Analysis]
66 Hong MH, Heo SG, Lee YG, Kim HS, Park KU, Kim HG, Ko YH, Chung IJ, Min YJ, Kim MK, Kim KR, Yoo J, Kim TM, Kim HR, Cho BC. Phase 2 study of afatinib among patients with recurrent and/or metastatic esophageal squamous cell carcinoma. Cancer 2020;126:4521-31. [PMID: 32749686 DOI: 10.1002/cncr.33123] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
67 Ko JMY, Lam SY, Ning L, Chai AWY, Lei LC, Choi SSA, Wong CWY, Lung ML. RAD50 Loss of Function Variants in the Zinc Hook Domain Associated with Higher Risk of Familial Esophageal Squamous Cell Carcinoma. Cancers (Basel) 2021;13:4715. [PMID: 34572942 DOI: 10.3390/cancers13184715] [Reference Citation Analysis]
68 Zhao S, Sun N, Yuan X, Shen Z, Zhu X, Li J. Genetic analysis of rapidly progressing esophageal squamous cell carcinoma: A case report. Medicine (Baltimore) 2021;100:e24462. [PMID: 33655918 DOI: 10.1097/MD.0000000000024462] [Reference Citation Analysis]
69 Letchumanan I, Gopinath SCB, Arshad MKM. Divalent ion-induced aggregation of gold nanoparticles for voltammetry Immunosensing: comparison of transducer signals in an assay for the squamous cell carcinoma antigen. Microchim Acta 2020;187. [DOI: 10.1007/s00604-020-4115-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
70 Zhang N, Zhang SW. Long-term effects of radiation prior to surgery and chemotherapy on survival of esophageal cancer undergoing surgery. Medicine (Baltimore) 2019;98:e17617. [PMID: 31651875 DOI: 10.1097/MD.0000000000017617] [Reference Citation Analysis]
71 Ekheden I, Yang X, Chen H, Chen X, Yuan Z, Jin L, Lu M, Ye W. Associations Between Gastric Atrophy and Its Interaction With Poor Oral Health and the Risk for Esophageal Squamous Cell Carcinoma in a High-Risk Region of China: A Population-Based Case-Control Study. Am J Epidemiol 2020;189:931-41. [PMID: 31899792 DOI: 10.1093/aje/kwz283] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
72 Ciccarelli FD. Mutations differ in normal and cancer cells of the oesophagus. Nature 2019;565:301-3. [PMID: 30643303 DOI: 10.1038/d41586-018-07737-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
73 Pan H, Zhou X, Zhao F, Lou G. The diagnosis of intramural esophageal squamous cell carcinoma without mucosal invasion using endoscopic ultrasound-guided fine needle aspiration biopsy: A case report. Medicine (Baltimore) 2020;99:e21099. [PMID: 32629742 DOI: 10.1097/MD.0000000000021099] [Reference Citation Analysis]
74 Wang S, Pan D, Zhang T, Su M, Sun G, Wei J, Guo Z, Wang K, Song G, Yan Q. Corn Flour Intake, Aflatoxin B1 Exposure, and Risk of Esophageal Precancerous Lesions in a High-Risk Area of Huai'an, China: A Case-Control Study. Toxins (Basel) 2020;12:E299. [PMID: 32384611 DOI: 10.3390/toxins12050299] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
75 Rajendra S, Pavey D, McKay O, Merrett N, Gautam SD. Human papillomavirus infection in esophageal squamous cell carcinoma and esophageal adenocarcinoma: a concise review. Ann N Y Acad Sci 2020;1482:36-48. [PMID: 33103249 DOI: 10.1111/nyas.14509] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
76 Chua T, Fukami N. Upfront endoscopic submucosal dissection for superficial squamous cell carcinoma is superior to upfront surgical therapy. Gastrointest Endosc 2018;88:634-6. [PMID: 30217240 DOI: 10.1016/j.gie.2018.07.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
77 Jiang D, Wang H, Song Q, Wang H, Wang Q, Tan L, Hou Y. Comparison of the prognostic difference between ypTNM and equivalent pTNM stages in esophageal squamous cell carcinoma based on the 8th edition of AJCC classification. J Cancer 2020;11:1808-15. [PMID: 32194792 DOI: 10.7150/jca.34567] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
78 Zhu Q, Huang L, Yang Q, Ao Z, Yang R, Krzesniak J, Lou D, Hu L, Dai X, Guo F, Liu F. Metabolomic analysis of exosomal-markers in esophageal squamous cell carcinoma. Nanoscale 2021;13:16457-64. [PMID: 34648610 DOI: 10.1039/d1nr04015d] [Reference Citation Analysis]
79 Feng C, Li P, Zhang F, Chen H, Yu P. A Meta-Analysis of the Association Between the VEGF +936C>T Gene Polymorphism and Digestive System Cancer Susceptibility. Genet Test Mol Biomarkers 2020;24:732-44. [PMID: 33186081 DOI: 10.1089/gtmb.2020.0136] [Reference Citation Analysis]
80 Guo YN, Tian DP, Gong QY, Huang H, Yang P, Chen SB, Billan S, He JY, Huang HH, Xiong P, Lin WT, Guo D, Marom M, Gil Z, Su M. Perineural Invasion is a Better Prognostic Indicator than Lymphovascular Invasion and a Potential Adjuvant Therapy Indicator for pN0M0 Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 2020;27:4371-81. [PMID: 32519146 DOI: 10.1245/s10434-020-08667-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
81 Du K, Li L, Wang Q, Zou J, Yu Z, Li J, Zheng Y. Development and application of a dynamic prediction model for esophageal cancer. Ann Transl Med 2021;9:1546. [PMID: 34790752 DOI: 10.21037/atm-21-4964] [Reference Citation Analysis]
82 Zhang L, Wang L, Lu N, Wang J, Yan R, Yan H, Zhang J, Zhang M. Micro RNA-363 inhibits esophageal squamous cell carcinoma progression by directly targeting sperm-associated antigen 5. J Int Med Res 2020;48:300060520932795. [PMID: 32586155 DOI: 10.1177/0300060520932795] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Liu F, Liu M, Liu Y, Guo C, Zhou Y, Li F, Xu R, Liu Z, Deng Q, Li X, Zhang C, Pan Y, Ning T, Dong X, Hu Z, Bao H, Cai H, Silva IDS, He Z, Ke Y. Oral microbiome and risk of malignant esophageal lesions in a high-risk area of China: A nested case-control study. Chin J Cancer Res 2020;32:742-54. [PMID: 33446997 DOI: 10.21147/j.issn.1000-9604.2020.06.07] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
84 Zou XZ, Zhou XH, Feng YQ, Hao JF, Liang B, Jia MW. Novel inhibitor of OCT1 enhances the sensitivity of human esophageal squamous cell carcinoma cells to antitumor agents. Eur J Pharmacol 2021;907:174222. [PMID: 34087221 DOI: 10.1016/j.ejphar.2021.174222] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
85 Xie Y, Shi L, He X, Luo Y. Gastrointestinal cancers in China, the USA, and Europe. Gastroenterol Rep (Oxf) 2021;9:91-104. [PMID: 34026216 DOI: 10.1093/gastro/goab010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
86 Middleton DRS, Mmbaga BT, Menya D, Dzamalala C, Nyakunga-maro G, Finch P, Mlombe Y, Schüz J, Mccormack V, Kigen N, Oduor M, Karuru Maina S, Some F, Kibosia C, Mwasamwaja A, Mremi A, Kiwelu I, Swai R, Kiwelu G, Mustapha S, Mghase E, Mchome A, Shao R, Mallya E, Kilonzo K, Kamkwantira A, Kamdolozi M, Liomba G, Chasimpha S, Narh C, Bouaoun L, Abedi-ardekani B, Mushi G, Namwai T, Suwedi M, Solomon T, Malamba R, Carreira C. Alcohol consumption and oesophageal squamous cell cancer risk in east Africa: findings from the large multicentre ESCCAPE case-control study in Kenya, Tanzania, and Malawi. The Lancet Global Health 2022;10:e236-45. [DOI: 10.1016/s2214-109x(21)00506-4] [Reference Citation Analysis]
87 Deng Y, Tang D, Hou P, Shen W, Li H, Wang T, Liu R. Dysbiosis of gut microbiota in patients with esophageal cancer. Microb Pathog 2021;150:104709. [PMID: 33378710 DOI: 10.1016/j.micpath.2020.104709] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
88 Qin B, Dong M, Wang Z, Wan J, Xie Y, Jiao Y, Yan D. Long non‑coding RNA CASC15 facilitates esophageal squamous cell carcinoma tumorigenesis via decreasing SIM2 stability via FTO‑mediated demethylation. Oncol Rep 2021;45:1059-71. [PMID: 33650646 DOI: 10.3892/or.2020.7917] [Reference Citation Analysis]
89 Zhang PF, Xie D, Li Q. Cost-effectiveness analysis of nivolumab in the second-line treatment for advanced esophageal squamous cell carcinoma. Future Oncol 2020;16:1189-98. [PMID: 32407173 DOI: 10.2217/fon-2019-0821] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
90 Yeh JH, Huang RY, Lee CT, Lin CW, Hsu MH, Wu TC, Hsiao PJ, Wang WL. Long-term outcomes of endoscopic submucosal dissection and comparison to surgery for superficial esophageal squamous cancer: a systematic review and meta-analysis. Therap Adv Gastroenterol 2020;13:1756284820964316. [PMID: 33224272 DOI: 10.1177/1756284820964316] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
91 Accordino G, Lettieri S, Bortolotto C, Benvenuti S, Gallotti A, Gattoni E, Agustoni F, Pozzi E, Rinaldi P, Primiceri C, Morbini P, Lancia A, Stella GM. From Interconnection between Genes and Microenvironment to Novel Immunotherapeutic Approaches in Upper Gastro-Intestinal Cancers-A Multidisciplinary Perspective. Cancers (Basel) 2020;12:E2105. [PMID: 32751137 DOI: 10.3390/cancers12082105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
92 Qian CJ, Xu ZR, Chen LY, Wang YC, Yao J. LncRNA MAFG-AS1 Accelerates Cell Migration, Invasion and Aerobic Glycolysis of Esophageal Squamous Cell Carcinoma Cells via miR-765/PDX1 Axis. Cancer Manag Res 2020;12:6895-908. [PMID: 32801913 DOI: 10.2147/CMAR.S262075] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
93 Weygant N, Chang K, Jackson CS, Vega KJ. Sex-Associated Gene Expression Alterations Correlate With Esophageal Cancer Survival. Clin Transl Gastroenterol 2020;12:e00281. [PMID: 33464731 DOI: 10.14309/ctg.0000000000000281] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
94 Matejcic M, Mathew CG, Parker MI. The Relationship Between Environmental Exposure and Genetic Architecture of the 2q33 Locus With Esophageal Cancer in South Africa. Front Genet 2019;10:406. [PMID: 31118947 DOI: 10.3389/fgene.2019.00406] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
95 Yano Y, Etemadi A, Abnet CC. Microbiome and Cancers of the Esophagus: A Review. Microorganisms 2021;9:1764. [PMID: 34442842 DOI: 10.3390/microorganisms9081764] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
96 Yasumizu Y, Sakaue S, Konuma T, Suzuki K, Matsuda K, Murakami Y, Kubo M, Palamara PF, Kamatani Y, Okada Y. Genome-Wide Natural Selection Signatures Are Linked to Genetic Risk of Modern Phenotypes in the Japanese Population. Mol Biol Evol 2020;37:1306-16. [PMID: 31957793 DOI: 10.1093/molbev/msaa005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
97 Wei WQ, Hao CQ, Guan CT, Song GH, Wang M, Zhao DL, Li BY, Bai WL, Hou PY, Wang JW, Jin GL, Lei FH, Li XQ, Xue LY, Wang GQ, Abnet CC, Taylor PR, Dawsey SM, Qiao YL. Esophageal Histological Precursor Lesions and Subsequent 8.5-Year Cancer Risk in a Population-Based Prospective Study in China. Am J Gastroenterol 2020;115:1036-44. [PMID: 32618654 DOI: 10.14309/ajg.0000000000000640] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
98 Arnold M, Morgan E, Bardot A, Rutherford MJ, Ferlay J, Little A, Møller B, Bucher O, De P, Woods RR, Saint-Jacques N, Gavin AT, Engholm G, Achiam MP, Porter G, Walsh PM, Vernon S, Kozie S, Ramanakumar AV, Lynch C, Harrison S, Merrett N, O'Connell DL, Mala T, Elwood M, Zalcberg J, Huws DW, Ransom D, Bray F, Soerjomataram I. International variation in oesophageal and gastric cancer survival 2012-2014: differences by histological subtype and stage at diagnosis (an ICBP SURVMARK-2 population-based study). Gut 2021:gutjnl-2021-325266. [PMID: 34824149 DOI: 10.1136/gutjnl-2021-325266] [Reference Citation Analysis]
99 Shiflett BS, Ekanayake LS, Rodriguez AL, Ikramuddin I, Myers C. Esophageal Adenocarcinoma in the Proximal Esophageal Segment: A Unique Presentation in a Male With Alcohol Abuse. Cureus 2020;12:e8863. [PMID: 32754402 DOI: 10.7759/cureus.8863] [Reference Citation Analysis]
100 Shen JF, Ge JF, Zheng SY, Jiang D. Integrative analysis of differential circular RNA and long non-coding RNA profiles and associated competing endogenous RNA networks in esophageal squamous cell carcinoma. Funct Integr Genomics 2021;21:125-38. [PMID: 33415515 DOI: 10.1007/s10142-020-00765-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
101 Zhang N, Ren Y, Wang Y, Zhao L, Wang B, Ma N, Gao Z, Cao B. LRG1 Suppresses Migration and Invasion of Esophageal Squamous Cell Carcinoma by Modulating Epithelial to Mesenchymal Transition. J Cancer 2020;11:1486-94. [PMID: 32047555 DOI: 10.7150/jca.36189] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
102 Suzuki L, Ten Kate FJC, Gotink AW, Stoop H, Doukas M, Nieboer D, Spaander MCW, van Lanschot JJB, van Wijnhoven BPL, Koch AD, Bruno MJ, Looijenga LHJ, Biermann K. Olfactomedin 4 (OLFM4) expression is associated with nodal metastases in esophageal adenocarcinoma. PLoS One 2019;14:e0219494. [PMID: 31283789 DOI: 10.1371/journal.pone.0219494] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
103 Ma S, Liu T, Xu L, Wang Y, Zhou J, Huang T, Li P, Liu H, Zhang Y, Zhou X, Cui Y, Zang X, Wang Y, Guan F. Histone deacetylases inhibitor MS-275 suppresses human esophageal squamous cell carcinoma cell growth and progression via the PI3K/Akt/mTOR pathway. J Cell Physiol 2019;234:22400-10. [PMID: 31120582 DOI: 10.1002/jcp.28805] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
104 Ishibashi Y, Tsujimoto H, Sugasawa H, Kouzu K, Itazaki Y, Sugihara T, Harada M, Ito N, Kishi Y, Ueno H. Prognostic value of platelet-related measures for overall survival in esophageal squamous cell carcinoma: A systematic review and meta-analysis. Crit Rev Oncol Hematol 2021;164:103427. [PMID: 34273499 DOI: 10.1016/j.critrevonc.2021.103427] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
105 Yang W, Xing X, Yeung SJ, Wang S, Chen W, Bao Y, Wang F, Feng S, Peng F, Wang X, Chen S, He M, Zhang N, Wang H, Zeng B, Liu Z, Kidane B, Seder CW, Koyanagi K, Shargall Y, Luo H, Peng S, Cheng C. Neoadjuvant programmed cell death 1 blockade combined with chemotherapy for resectable esophageal squamous cell carcinoma. J Immunother Cancer 2022;10:e003497. [PMID: 35022193 DOI: 10.1136/jitc-2021-003497] [Reference Citation Analysis]
106 Niu C, Liu Y, Wang J, Liu Y, Zhang S, Zhang Y, Zhang L, Zhao D, Liu F, Chao L, Wang X, Zhang C, Song G, Zhang Z, Li Y, Yan Z, Wen Y, Ge Y, Zang Z, Feng W, Zhang H, Tao L, Nakyeyune R, Shen Y, Shao Y, Guo X, Miles T, Yang A, Liu F, Wang G. Risk factors for esophageal squamous cell carcinoma and its histological precursor lesions in China: a multicenter cross-sectional study. BMC Cancer 2021;21:1034. [PMID: 34530751 DOI: 10.1186/s12885-021-08764-x] [Reference Citation Analysis]
107 Islami F, DeSantis CE, Jemal A. Incidence Trends of Esophageal and Gastric Cancer Subtypes by Race, Ethnicity, and Age in the United States, 1997-2014. Clin Gastroenterol Hepatol. 2019;17:429-439. [PMID: 29902641 DOI: 10.1016/j.cgh.2018.05.044] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 8.5] [Reference Citation Analysis]
108 Gao H, Wang T, Zhang P, Shang M, Gao Z, Yang F, Liu R. Linc-ROR regulates apoptosis in esophageal squamous cell carcinoma via modulation of p53 ubiquitination by targeting miR-204-5p/MDM2. J Cell Physiol 2020;235:2325-35. [PMID: 31541467 DOI: 10.1002/jcp.29139] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
109 Zhu ZJ, Qi Z, Zhang J, Xue WH, Li LF, Shen ZB, Li ZY, Yuan YL, Wang WB, Zhao J. Untargeted Metabolomics Analysis of Esophageal Squamous Cell Carcinoma Discovers Dysregulated Metabolic Pathways and Potential Diagnostic Biomarkers. J Cancer 2020;11:3944-54. [PMID: 32328198 DOI: 10.7150/jca.41733] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
110 Kalhori MR, Soleimani M, Arefian E, Alizadeh AM, Mansouri K, Echeverria J. The potential role of miR-1290 in cancer progression, diagnosis, prognosis, and treatment: An oncomiR or onco-suppressor microRNA? J Cell Biochem 2021. [PMID: 34897783 DOI: 10.1002/jcb.30191] [Reference Citation Analysis]
111 Duan Y, Jia Y, Wang J, Liu T, Cheng Z, Sang M, Lv W, Qin J, Liu L. Long noncoding RNA DGCR5 involves in tumorigenesis of esophageal squamous cell carcinoma via SRSF1-mediated alternative splicing of Mcl-1. Cell Death Dis 2021;12:587. [PMID: 34099633 DOI: 10.1038/s41419-021-03858-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
112 Lan T, Xue X, Dunmall LC, Miao J, Wang Y. Patient-derived xenograft: a developing tool for screening biomarkers and potential therapeutic targets for human esophageal cancers. Aging (Albany NY) 2021;13:12273-93. [PMID: 33903283 DOI: 10.18632/aging.202934] [Reference Citation Analysis]
113 Zhang C, Zhang Z, Zhang G, Xue L, Yang H, Luo Y, Zheng X, Zhang Y, Yuan Y, Lei R, Yang Z, Zheng B, Zhang Z, Wang L, Che Y, Wang S, Wang F, Fang L, Zeng Q, Li J, Gao S, Xue Q, Sun N, He J. A three-lncRNA signature of pretreatment biopsies predicts pathological response and outcome in esophageal squamous cell carcinoma with neoadjuvant chemoradiotherapy. Clin Transl Med 2020;10:e156. [PMID: 32898328 DOI: 10.1002/ctm2.156] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
114 Cheng Y, Fang Q, Chen Y, Zang G, Yao J. High Expression of Tumor Abnormal Protein Preoperatively Predicts Poor Prognosis of Patients With Esophageal Squamous Cell Carcinoma. Front Surg 2021;8:609719. [PMID: 33718426 DOI: 10.3389/fsurg.2021.609719] [Reference Citation Analysis]
115 Then EO, Lopez M, Saleem S, Gayam V, Sunkara T, Culliford A, Gaduputi V. Esophageal Cancer: An Updated Surveillance Epidemiology and End Results Database Analysis. World J Oncol 2020;11:55-64. [PMID: 32284773 DOI: 10.14740/wjon1254] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 17.5] [Reference Citation Analysis]
116 Wakita A, Motoyama S, Sato Y, Kawakita Y, Nagaki Y, Terata K, Imai K, Minamiya Y. Evaluation of metastatic lymph nodes in cN0 thoracic esophageal cancer patients with inconsistent pathological lymph node diagnosis. World J Surg Oncol 2020;18:111. [PMID: 32471425 DOI: 10.1186/s12957-020-01880-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
117 Lin J, Liu Z, Liao S, Li E, Wu X, Zeng W. Elevation of long non-coding RNA GAS5 and knockdown of microRNA-21 up-regulate RECK expression to enhance esophageal squamous cell carcinoma cell radio-sensitivity after radiotherapy. Genomics 2020;112:2173-85. [PMID: 31866421 DOI: 10.1016/j.ygeno.2019.12.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
118 Li S, Chung DC, Mullen JT. Screening high-risk populations for esophageal and gastric cancer. J Surg Oncol. 2019;120:831-846. [PMID: 31373005 DOI: 10.1002/jso.25656] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
119 Simba H, Kuivaniemi H, Lutje V, Tromp G, Sewram V. Systematic Review of Genetic Factors in the Etiology of Esophageal Squamous Cell Carcinoma in African Populations. Front Genet 2019;10:642. [PMID: 31428123 DOI: 10.3389/fgene.2019.00642] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
120 Song W, Wang K, Yang X, Dai W, Fan Z. Long non‑coding RNA BANCR mediates esophageal squamous cell carcinoma progression by regulating the IGF1R/Raf/MEK/ERK pathway via miR‑338‑3p. Int J Mol Med 2020;46:1377-88. [PMID: 32945416 DOI: 10.3892/ijmm.2020.4687] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
121 Bensen R, Brognard J. New Therapeutic Opportunities for the Treatment of Squamous Cell Carcinomas: A Focus on Novel Driver Kinases. Int J Mol Sci 2021;22:2831. [PMID: 33799513 DOI: 10.3390/ijms22062831] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
122 Wu LL, Ma QL, Huang W, Liu X, Qiu LH, Lin P, Long H, Zhang LJ, Ma GW. A prognostic model for stratification of stage IB/IIA esophageal squamous cell carcinoma: a retrospective study. BMC Gastroenterol 2021;21:59. [PMID: 33568088 DOI: 10.1186/s12876-021-01636-5] [Reference Citation Analysis]
123 Shi Z, Zhu X, Ke S, Qiu H, Cai G, Zhangcai Y, Chen Y. Survival impact of concurrent chemoradiotherapy for elderly patients with synchronous oligometastatic esophageal squamous cell carcinoma: A propensity score matching and landmark analyses. Radiother Oncol 2021;164:236-44. [PMID: 34627936 DOI: 10.1016/j.radonc.2021.09.033] [Reference Citation Analysis]
124 Li MX, Sun XM, Cheng WG, Ruan HJ, Liu K, Chen P, Xu HJ, Gao SG, Feng XS, Qi YJ. Using a machine learning approach to identify key prognostic molecules for esophageal squamous cell carcinoma. BMC Cancer 2021;21:906. [PMID: 34372798 DOI: 10.1186/s12885-021-08647-1] [Reference Citation Analysis]
125 Chen R, Ma S, Guan C, Song G, Ma Q, Xie S, Wang M, Shao D, Li X, Wei W. The National Cohort of Esophageal Cancer-Prospective Cohort Study of Esophageal Cancer and Precancerous Lesions based on High-Risk Population in China (NCEC-HRP): study protocol. BMJ Open 2019;9:e027360. [PMID: 30948615 DOI: 10.1136/bmjopen-2018-027360] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
126 Han J, Wang L, Zhang H, Ma S, Li Y, Wang Z, Zhu G, Zhao D, Wang J, Xue F. Development and Validation of an Esophageal Squamous Cell Carcinoma Risk Prediction Model for Rural Chinese: Multicenter Cohort Study. Front Oncol 2021;11:729471. [PMID: 34527592 DOI: 10.3389/fonc.2021.729471] [Reference Citation Analysis]
127 Tian B, Xiao Y, Ma J, Ou W, Wang H, Wu J, Tang J, Zhang B, Liao X, Yang D, Wu Z, Li X, Zhou Y, Su M, Wang W. Parthenolide Inhibits Angiogenesis in Esophageal Squamous Cell Carcinoma Through Suppression of VEGF. Onco Targets Ther 2020;13:7447-58. [PMID: 32801767 DOI: 10.2147/OTT.S256291] [Reference Citation Analysis]
128 Yang C, Guo Z, Zhao Z, Wei Y, Wang X, Song Y. miR-4306 Suppresses Proliferation of Esophageal Squamous Cell Carcinoma Cell by Targeting SIX3. Cell Biochem Biophys 2021. [PMID: 34021861 DOI: 10.1007/s12013-021-00994-x] [Reference Citation Analysis]
129 Zhang Y, Li J, Wang L, Meng P, Zhao J, Han P, Xia J, Xu J, Wang L, Shen F, Zheng A, Zhou F, Fan R. Clinical significance of detecting circulating tumor cells in patients with esophageal squamous cell carcinoma by EpCAM‑independent enrichment and immunostaining‑fluorescence in situ hybridization. Mol Med Rep 2019;20:1551-60. [PMID: 31257510 DOI: 10.3892/mmr.2019.10420] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
130 Zhang Q, Wu P, He X, Ding Y, Shu Y. Cost-Effectiveness Analysis of Camrelizumab vs. Placebo Added to Chemotherapy as First-Line Therapy for Advanced or Metastatic Esophageal Squamous Cell Carcinoma in China. Front Oncol 2021;11:790373. [PMID: 34926306 DOI: 10.3389/fonc.2021.790373] [Reference Citation Analysis]
131 Li N, Zhao Z, Liu P, Zheng Y, Cai S, Sun Y, Wang B. Upregulation of deubiquitinase USP7 by transcription factor FOXO6 promotes EC progression via targeting the JMJD3/CLU axis. Mol Ther Oncolytics 2021;20:583-95. [PMID: 33768140 DOI: 10.1016/j.omto.2020.12.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
132 Zhao D, Chen J, Wang Y, Zhang L, Zhang J, Zhang W, Fan J, Li J, Zhan Q. Feed-forward activation of STAT3 signaling limits the efficacy of c-Met inhibitors in esophageal squamous cell carcinoma (ESCC) treatment. Mol Carcinog 2021;60:481-96. [PMID: 34018249 DOI: 10.1002/mc.23306] [Reference Citation Analysis]
133 Fabian T, Leung A. Epidemiology of Barrett's Esophagus and Esophageal Carcinoma. Surg Clin North Am 2021;101:381-9. [PMID: 34048759 DOI: 10.1016/j.suc.2021.03.001] [Reference Citation Analysis]
134 Ma F, Laster K, Nie W, Liu F, Kim DJ, Lee MH, Bai R, Yang R, Liu K, Dong Z. Heterogeneity Analysis of Esophageal Squamous Cell Carcinoma in Cell Lines, Tumor Tissues and Patient-Derived Xenografts. J Cancer 2021;12:3930-44. [PMID: 34093800 DOI: 10.7150/jca.52286] [Reference Citation Analysis]
135 Zhang Y, Gao J, Zheng A, Yang H, Li J, Wu S, Zhao J, Meng P, Zhou F. Definition and risk factors of early recurrence based on affecting prognosis of esophageal squamous cell carcinoma patients after radical resection. Transl Oncol 2021;14:101066. [PMID: 33744728 DOI: 10.1016/j.tranon.2021.101066] [Reference Citation Analysis]
136 Jooste V, Manfredi S, Napoleon M, Drouillard A, Marref I, Bedenne L, Faivre J, Bouvier A. Patterns of care and outcomes in oesophageal cancer. Digestive and Liver Disease 2018;50:1238-43. [DOI: 10.1016/j.dld.2018.07.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
137 Le Compte M, Komen N, Joye I, Peeters M, Prenen H, Smits E, Deben C, de Maat M. Patient-derived organoids as individual patient models for chemoradiation response prediction in gastrointestinal malignancies. Crit Rev Oncol Hematol 2021;157:103190. [PMID: 33310278 DOI: 10.1016/j.critrevonc.2020.103190] [Reference Citation Analysis]
138 Li J, Xu J, Zheng Y, Gao Y, He S, Li H, Zou K, Li N, Tian J, Chen W, He J. Esophageal cancer: Epidemiology, risk factors and screening. Chin J Cancer Res 2021;33:535-47. [PMID: 34815628 DOI: 10.21147/j.issn.1000-9604.2021.05.01] [Reference Citation Analysis]
139 Zhu ZY, Luo RJ, He ZF, Xu Y, Xu SH, Zhang Q. Learning Curve for Lymph Node Dissection Around the Recurrent Laryngeal Nerve in McKeown Minimally Invasive Esophagectomy. Front Oncol 2021;11:654674. [PMID: 34094944 DOI: 10.3389/fonc.2021.654674] [Reference Citation Analysis]
140 Mu L, Song Y, Zhao K, Liu Y, Fan Q, Wang X, Li Q, Wang X, Huang J. SHR-1316, an anti-PD-L1 antibody, plus chemotherapy as the first-line treatment for advanced esophageal squamous cell carcinoma: A multicentre, phase 2 study. Thorac Cancer 2021;12:1373-81. [PMID: 33760397 DOI: 10.1111/1759-7714.13913] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
141 Jiang YY, Jiang Y, Li CQ, Zhang Y, Dakle P, Kaur H, Deng JW, Lin RY, Han L, Xie JJ, Yan Y, Doan N, Zheng Y, Mayakonda A, Hazawa M, Xu L, Li Y, Aswad L, Jeitany M, Kanojia D, Guan XY, Said JW, Yang W, Fullwood MJ, Lin DC, Koeffler HP. TP63, SOX2, and KLF5 Establish a Core Regulatory Circuitry That Controls Epigenetic and Transcription Patterns in Esophageal Squamous Cell Carcinoma Cell Lines. Gastroenterology 2020;159:1311-1327.e19. [PMID: 32619460 DOI: 10.1053/j.gastro.2020.06.050] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
142 Li D, Yan M, Sun F, Song J, Hu X, Yu S, Tang L, Deng S. miR-498 inhibits autophagy and M2-like polarization of tumor-associated macrophages in esophageal cancer via MDM2/ATF3. Epigenomics 2021;13:1013-30. [PMID: 34114479 DOI: 10.2217/epi-2020-0341] [Reference Citation Analysis]
143 Liu XB, Gao ZY, Sun CT, Wen H, Gao B, Li SB, Tong Q. The potential role of P.gingivalis in gastrointestinal cancer: a mini review. Infect Agent Cancer 2019;14:23. [PMID: 31516546 DOI: 10.1186/s13027-019-0239-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
144 Wang ZQ, Wang DS, Wang FH, Ren C, Tan Q, Li YH. Recombinant human endostatin plus paclitaxel/nedaplatin for recurrent or metastatic advanced esophageal squamous cell carcinoma: a prospective, single-arm, open-label, phase II study. Invest New Drugs 2021;39:516-23. [PMID: 33070249 DOI: 10.1007/s10637-020-01021-1] [Reference Citation Analysis]
145 Wang Y, Guo H, Gao X, Wang J. The Intratumor Microbiota Signatures Associate With Subtype, Tumor Stage, and Survival Status of Esophageal Carcinoma. Front Oncol 2021;11:754788. [PMID: 34778069 DOI: 10.3389/fonc.2021.754788] [Reference Citation Analysis]
146 Lin JC, Zhu NX, Wu LF. Research progress of circRNAs in chemotherapy resistance of digestive system neoplasms. Shijie Huaren Xiaohua Zazhi 2021; 29(21): 1237-1247 [DOI: 10.11569/wcjd.v29.i21.1237] [Reference Citation Analysis]
147 Fan J, Liu Z, Mao X, Tong X, Zhang T, Suo C, Chen X. Global trends in the incidence and mortality of esophageal cancer from 1990 to 2017. Cancer Med 2020;9:6875-87. [PMID: 32750217 DOI: 10.1002/cam4.3338] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
148 Liang Y, Li S, Zheng G, Zhang L. β-elemene suppresses the malignant behavior of esophageal cancer cells by regulating the phosphorylation of AKT. Acta Histochemica 2020;122:151538. [DOI: 10.1016/j.acthis.2020.151538] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
149 Soroush A, Etemadi A, Abrams JA. Non-Acid Fluid Exposure and Esophageal Squamous Cell Carcinoma. Dig Dis Sci 2021. [PMID: 34236559 DOI: 10.1007/s10620-021-07127-7] [Reference Citation Analysis]
150 Cummings D, Wong J, Palm R, Hoffe S, Almhanna K, Vignesh S. Epidemiology, Diagnosis, Staging and Multimodal Therapy of Esophageal and Gastric Tumors. Cancers (Basel) 2021;13:582. [PMID: 33540736 DOI: 10.3390/cancers13030582] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
151 Khan T, Relitti N, Brindisi M, Magnano S, Zisterer D, Gemma S, Butini S, Campiani G. Autophagy modulators for the treatment of oral and esophageal squamous cell carcinomas. Med Res Rev 2020;40:1002-60. [PMID: 31742748 DOI: 10.1002/med.21646] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
152 Liu H, Zhang Q, Lou Q, Zhang X, Cui Y, Wang P, Yang F, Wu F, Wang J, Fan T, Li S. Differential Analysis of lncRNA, miRNA and mRNA Expression Profiles and the Prognostic Value of lncRNA in Esophageal Cancer. Pathol Oncol Res 2020;26:1029-39. [PMID: 30972633 DOI: 10.1007/s12253-019-00655-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
153 Wang M, Liu F, Pan Y, Xu R, Li F, Liu A, Yang H, Duan L, Shen L, Wu Q, Liu Y, Liu M, Liu Z, Hu Z, Chen H, Cai H, He Z, Ke Y. Tumor-associated autoantibodies in ESCC screening: Detecting prevalent early-stage malignancy or predicting future cancer risk? EBioMedicine 2021;73:103674. [PMID: 34753106 DOI: 10.1016/j.ebiom.2021.103674] [Reference Citation Analysis]
154 Moody S, Senkin S, Islam SMA, Wang J, Nasrollahzadeh D, Cortez Cardoso Penha R, Fitzgerald S, Bergstrom EN, Atkins J, He Y, Khandekar A, Smith-Byrne K, Carreira C, Gaborieau V, Latimer C, Thomas E, Abnizova I, Bucciarelli PE, Jones D, Teague JW, Abedi-Ardekani B, Serra S, Scoazec JY, Saffar H, Azmoudeh-Ardalan F, Sotoudeh M, Nikmanesh A, Poustchi H, Niavarani A, Gharavi S, Eden M, Richman P, Campos LS, Fitzgerald RC, Ribeiro LF, Soares-Lima SC, Dzamalala C, Mmbaga BT, Shibata T, Menya D, Goldstein AM, Hu N, Malekzadeh R, Fazel A, McCormack V, McKay J, Perdomo S, Scelo G, Chanudet E, Humphreys L, Alexandrov LB, Brennan P, Stratton MR. Mutational signatures in esophageal squamous cell carcinoma from eight countries with varying incidence. Nat Genet 2021;53:1553-63. [PMID: 34663923 DOI: 10.1038/s41588-021-00928-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
155 Han M, Li N, Li F, Wang H, Ma L. MiR-27b-3p exerts tumor suppressor effects in esophageal squamous cell carcinoma by targeting Nrf2. Hum Cell 2020;33:641-51. [PMID: 32419118 DOI: 10.1007/s13577-020-00329-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
156 Ma L, Li H, Lin Y, Wang G, Xu Q, Chen Y, Xiao K, Rao X. CircDUSP16 Contributes to Cell Development in Esophageal Squamous Cell Carcinoma by Regulating miR-497-5p/TKTL1 Axis. J Surg Res 2021;260:64-75. [PMID: 33326930 DOI: 10.1016/j.jss.2020.11.052] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
157 Urabe Y, Kagemoto K, Hayes CN, Nakamura K, Masuda K, Ono A, Tanaka S, Arihiro K, Chayama K. Genomic characterization of early-stage esophageal squamous cell carcinoma in a Japanese population. Oncotarget 2019;10:4139-48. [PMID: 31289612 DOI: 10.18632/oncotarget.27014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
158 Kang Z, Zhu J, Sun N, Zhang X, Liang G, Kou Y, Zhu H, Carbonelli C, Sakao Y, Zhang Y. COL11A1 promotes esophageal squamous cell carcinoma proliferation and metastasis and is inversely regulated by miR-335-5p. Ann Transl Med 2021;9:1577. [PMID: 34790783 DOI: 10.21037/atm-21-4951] [Reference Citation Analysis]
159 Karstens KF, Kempski J, Giannou AD, Pelczar P, Steglich B, Steurer S, Freiwald E, Woestemeier A, Konczalla L, Tachezy M, Reeh M, Bockhorn M, Perez D, Mann O, Lohse AW, Roesch T, Izbicki JR, Gagliani N, Huber S. Anti-inflammatory microenvironment of esophageal adenocarcinomas negatively impacts survival. Cancer Immunol Immunother 2020;69:1043-56. [PMID: 32100077 DOI: 10.1007/s00262-020-02517-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
160 Fatehi Hassanabad A, Chehade R, Breadner D, Raphael J. Esophageal carcinoma: Towards targeted therapies. Cell Oncol (Dordr) 2020;43:195-209. [PMID: 31848929 DOI: 10.1007/s13402-019-00488-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 27] [Article Influence: 7.0] [Reference Citation Analysis]
161 Zhao C, Zhou J, Gu Y, Pan E, Sun Z, Zhang H, Lu Q, Zhang Y, Yu X, Liu R, Pu Y, Yin L. Urinary exposure of N-nitrosamines and associated risk of esophageal cancer in a high incidence area in China. Science of The Total Environment 2020;738:139713. [DOI: 10.1016/j.scitotenv.2020.139713] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
162 Dinh HQ, Pan F, Wang G, Huang QF, Olingy CE, Wu ZY, Wang SH, Xu X, Xu XE, He JZ, Yang Q, Orsulic S, Haro M, Li LY, Huang GW, Breunig JJ, Koeffler HP, Hedrick CC, Xu LY, Lin DC, Li EM. Integrated single-cell transcriptome analysis reveals heterogeneity of esophageal squamous cell carcinoma microenvironment. Nat Commun 2021;12:7335. [PMID: 34921160 DOI: 10.1038/s41467-021-27599-5] [Reference Citation Analysis]
163 Wang Y, Xie Z, Lu H. Significance of halofuginone in esophageal squamous carcinoma cell apoptosis through HIF-1α-FOXO3a pathway. Life Sci 2020;257:118104. [PMID: 32679143 DOI: 10.1016/j.lfs.2020.118104] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
164 Peng T, Wang X, Li Z, Bi L, Gao J, Yang M, Wang Y, Yao X, Shan H, Jin H. Preclinical Evaluation of [64Cu]NOTA-CP01 as a PET Imaging Agent for Metastatic Esophageal Squamous Cell Carcinoma. Mol Pharm 2021;18:3638-48. [PMID: 34424706 DOI: 10.1021/acs.molpharmaceut.1c00600] [Reference Citation Analysis]
165 Qin Y, Taylor W, Bamlet WR, Ravindran A, Buglioni A, Cao X, Foote PH, Slettedahl SW, Mahoney DW, Albert PS, Kim S, Hu N, Taylor PR, Etemadi A, Sotoudeh M, Malekzadeh R, Abnet CC, Smyrk TC, Katzka D, Topazian MD, Dawsey SM, Ahlquist D, Kisiel JB, Iyer PG. Methylated DNA Markers of Esophageal Squamous Cancer and Dysplasia: An International Study. Cancer Epidemiol Biomarkers Prev 2020;29:2642-50. [PMID: 32948633 DOI: 10.1158/1055-9965.EPI-20-0616] [Reference Citation Analysis]
166 Li Q, Ma Q, Xu L, Gao C, Yao L, Wen J, Yang M, Cheng J, Zhou X, Zou J, Zhong X, Guo X. Human Telomerase Reverse Transcriptase as a Therapeutic Target of Dihydroartemisinin for Esophageal Squamous Cancer. Front Pharmacol 2021;12:769787. [PMID: 34744749 DOI: 10.3389/fphar.2021.769787] [Reference Citation Analysis]
167 Zare M, Hadi F, Alivand MR. Considering the downregulation of Tpm1.6 and Tpm1.7 in squamous cell carcinoma of esophagus as a potent biomarker. Per Med 2018;15:361-70. [PMID: 30259780 DOI: 10.2217/pme-2018-0015] [Reference Citation Analysis]
168 Sun CX, Zhu F, Qi L. Demethylated miR-216a Regulates High Mobility Group Box 3 Promoting Growth of Esophageal Cancer Cells Through Wnt/β-Catenin Pathway. Front Oncol 2021;11:622073. [PMID: 33842327 DOI: 10.3389/fonc.2021.622073] [Reference Citation Analysis]
169 Yang G, Su X, Yang H, Luo G, Gao C, Zheng Y, Xie W, Huang M, Bei T, Bai Y, Wang Z, Cai P, He H, Xiang J, Cai M, Zhang Y, Qu C, Fu J, Liu Q, Hu Y, Zhong J, Huang Y, Guo Q, Zhang X. Neoadjuvant programmed death-1 blockade plus chemotherapy in locally advanced esophageal squamous cell carcinoma. Ann Transl Med 2021;9:1254. [PMID: 34532391 DOI: 10.21037/atm-21-3352] [Reference Citation Analysis]
170 Reichenbach ZW, Murray MG, Saxena R, Farkas D, Karassik EG, Klochkova A, Patel K, Tice C, Hall TM, Gang J, Parkman HP, Ward SJ, Tétreault M, Whelan KA. Clinical and translational advances in esophageal squamous cell carcinoma. Elsevier; 2019. pp. 95-135. [DOI: 10.1016/bs.acr.2019.05.004] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
171 Yang Y, Jia J, Sun Z, Liu C, Xiao Y, Yu J, Du F, Zhang X. Association Between Multiple Lines of Active Therapy and Prognosis in Esophageal Squamous Cell Carcinoma. Cancer Manag Res 2020;12:2177-84. [PMID: 32273757 DOI: 10.2147/CMAR.S242780] [Reference Citation Analysis]
172 Joachim C, Almont T, Drame M, Contaret C, Vestris M, Najioullah F, Aline-Fardin A, Escarmant P, Leduc N, Grossat N, Promeyrat X, Bougas S, Papadopoulou E, Vinh-Hung V, Sylvestre E, Veronique-Baudin J. International cooperation in public health in Martinique: geostrategic utility for cancer surveillance in the Caribbean. Global Health 2020;16:20. [PMID: 32131844 DOI: 10.1186/s12992-020-00551-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
173 Liu Z, Wu K, Gu S, Wang W, Xie S, Lu T, Li L, Dong C, Wang X, Zhou Y. A methyltransferase-like 14/miR-99a-5p/tribble 2 positive feedback circuit promotes cancer stem cell persistence and radioresistance via histone deacetylase 2-mediated epigenetic modulation in esophageal squamous cell carcinoma. Clin Transl Med 2021;11:e545. [PMID: 34586732 DOI: 10.1002/ctm2.545] [Reference Citation Analysis]
174 Yang X, Lu Q, Xu Y, Liu C, Sun Q. Clinicopathologic significance of CXCR4 expressions in patients with esophageal squamous cell carcinoma. Pathol Res Pract 2020;216:152787. [PMID: 31859114 DOI: 10.1016/j.prp.2019.152787] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
175 Wu Y, Zhi L, Zhao Y, Yang L, Cai F. Knockdown of circular RNA UBAP2 inhibits the malignant behaviours of esophageal squamous cell carcinoma by microRNA-422a/Rab10 axis. Clin Exp Pharmacol Physiol 2020;47:1283-90. [PMID: 32012318 DOI: 10.1111/1440-1681.13269] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
176 Aoyama J, Kawakubo H, Mayanagi S, Fukuda K, Irino T, Nakamura R, Wada N, Suzuki T, Kameyama K, Kitagawa Y. Discrepancy Between the Clinical and Final Pathological Findings of Lymph Node Metastasis in Superficial Esophageal Cancer. Ann Surg Oncol. 2019;26:2874-2881. [PMID: 31209674 DOI: 10.1245/s10434-019-07498-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
177 Huang H, Xue Q, Du X, Cui J, Wang J, Cheng D, Li J, Zheng Y, Huang G, Zhang K, Liu K, Lu J, Zhao J, Chen X, Dong Z, Li X. p21-activated kinase 4 promotes the progression of esophageal squamous cell carcinoma by targeting LASP1. Mol Carcinog 2020. [PMID: 33289209 DOI: 10.1002/mc.23269] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
178 Suzuki T, Furukawa K, Funasaka K, Ishikawa E, Sawada T, Maeda K, Yamamura T, Ishikawa T, Ohno E, Nakamura M, Kawashima H, Miyahara R, Fujishiro M. Long-Term Prognostic Predictors of Esophageal Squamous Cell Carcinoma Potentially Indicated for Endoscopic Submucosal Dissection. Digestion 2021;102:563-71. [PMID: 32894837 DOI: 10.1159/000510091] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
179 Businello G, Parente P, Mastracci L, Pennelli G, Traverso G, Milione M, Bellan E, Michelotto M, Kotsafti A, Grillo F, Fassan M. The Pathologic and Molecular Landscape of Esophageal Squamous Cell Carcinogenesis. Cancers (Basel) 2020;12:E2160. [PMID: 32759723 DOI: 10.3390/cancers12082160] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
180 Yang Z, Zhang C, Feng Y, Qi W, Cui Y, Xuan Y. Tenascin-C is involved in promotion of cancer stemness via the Akt/HIF1ɑ axis in esophageal squamous cell carcinoma. Exp Mol Pathol 2019;109:104239. [PMID: 30904401 DOI: 10.1016/j.yexmp.2019.03.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
181 Wakita A, Motoyama S, Sato Y, Nagaki Y, Fujita H, Terata K, Imai K, Maeda E, Minamiya Y. IGF2BP3 Expression Correlates With Poor Prognosis in Esophageal Squamous Cell Carcinoma. J Surg Res 2021;259:137-44. [PMID: 33279839 DOI: 10.1016/j.jss.2020.10.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
182 Fei Z, Xie R, Chen Z, Xie J, Gu Y, Zhou Y, Xu T. Establishment of a Novel Risk Score System of Immune Genes Associated With Prognosis in Esophageal Carcinoma. Front Oncol 2021;11:625271. [PMID: 33859939 DOI: 10.3389/fonc.2021.625271] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
183 Liang G, Wang H, Shi H, Zhu M, An J, Qi Y, Du J, Li Y, Gao S. Porphyromonas gingivalis Promotes the Proliferation and Migration of Esophageal Squamous Cell Carcinoma through the miR-194/GRHL3/PTEN/Akt Axis. ACS Infect Dis 2020;6:871-81. [PMID: 32298082 DOI: 10.1021/acsinfecdis.0c00007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
184 Zeng B, Liu Z, Zhu H, Zhang X, Yang W, Li X, Cheng C. CircRNA_2646 functions as a ceRNA to promote progression of esophageal squamous cell carcinoma via inhibiting miR-124/PLP2 signaling pathway. Cell Death Discov 2021;7:99. [PMID: 33976115 DOI: 10.1038/s41420-021-00461-9] [Reference Citation Analysis]
185 Zhao Q, Miao C, Lu Q, Wu W, He Y, Wu S, Liu H, Lian C. Clinical Significance of Monitoring Circulating Free DNA and Plasma Heat Shock Protein 90alpha in Patients with Esophageal Squamous Cell Carcinoma. Cancer Manag Res 2021;13:2223-34. [PMID: 33707971 DOI: 10.2147/CMAR.S295927] [Reference Citation Analysis]
186 Seisenova A, Daniyarov A, Molkenov A, Sharip A, Zinovyev A, Kairov U. Meta-Analysis of Esophageal Cancer Transcriptomes Using Independent Component Analysis. Front Genet 2021;12:683632. [PMID: 34795689 DOI: 10.3389/fgene.2021.683632] [Reference Citation Analysis]
187 Boon SS, Chen Z, Li J, Lee KYC, Cai L, Zhong R, Chan PKS. Human papillomavirus type 18 oncoproteins exert their oncogenicity in esophageal and tongue squamous cell carcinoma cell lines distinctly. BMC Cancer 2019;19:1211. [PMID: 31830929 DOI: 10.1186/s12885-019-6413-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
188 Zheng Y, Chen Y, Jiang H, Zhang H, Wang H, Xu J, Yu Z. Circ_0058063 upregulates GLUT1 expression and promotes glucose-uptake in esophageal squamous-cell carcinomas. J Thorac Dis 2020;12:925-31. [PMID: 32274160 DOI: 10.21037/jtd.2019.12.57] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
189 Chen ZX, Li GS, Yang LH, Liu HC, Qin GM, Shen L, He WY, Gan TQ, Li JJ. Upregulation of BIRC5 plays essential role in esophageal squamous cell carcinoma. Math Biosci Eng 2021;18:6941-60. [PMID: 34517565 DOI: 10.3934/mbe.2021345] [Reference Citation Analysis]
190 Tian B, Liu J, Zhang N, Song Y, Xu Y, Xie M, Wang B, Hua H, Shen Y, Li Y, Yang M. Oncogenic SNORD12B activates the AKT-mTOR-4EBP1 signaling in esophageal squamous cell carcinoma via nucleus partitioning of PP-1α. Oncogene 2021;40:3734-47. [PMID: 33941854 DOI: 10.1038/s41388-021-01809-2] [Reference Citation Analysis]
191 Hou Y, Liu H, Pan W. Knockdown of circ_0003340 induces cell apoptosis, inhibits invasion and proliferation through miR-564/TPX2 in esophageal cancer cells. Exp Cell Res 2020;394:112142. [PMID: 32535036 DOI: 10.1016/j.yexcr.2020.112142] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
192 Reich M, Coutzac C. [New AMM: Nivolumab for advanced oesophageal squamous cell carcinomia after first line of chemotherapy]. Bull Cancer 2021;108:228-9. [PMID: 33531154 DOI: 10.1016/j.bulcan.2020.12.005] [Reference Citation Analysis]
193 Liu F, Wu Q, Han W, Laster K, Hu Y, Ma F, Chen H, Tian X, Qiao Y, Liu H, Kim DJ, Dong Z, Liu K. Targeting integrin αvβ3 with indomethacin inhibits patient-derived xenograft tumour growth and recurrence in oesophageal squamous cell carcinoma. Clin Transl Med 2021;11:e548. [PMID: 34709754 DOI: 10.1002/ctm2.548] [Reference Citation Analysis]
194 Zhou J, Sun S, Luan S, Xiao X, Yang Y, Mao C, Chen L, Zeng X, Zhang Y, Yuan Y. Gut Microbiota for Esophageal Cancer: Role in Carcinogenesis and Clinical Implications. Front Oncol 2021;11:717242. [PMID: 34733778 DOI: 10.3389/fonc.2021.717242] [Reference Citation Analysis]
195 Zhang C, Xie L, Fu Y, Yang J, Cui Y. lncRNA MIAT promotes esophageal squamous cell carcinoma progression by regulating miR-1301-3p/INCENP axis and interacting with SOX2. J Cell Physiol 2020;235:7933-44. [PMID: 31943174 DOI: 10.1002/jcp.29448] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
196 Zhou C, Fan N, Liu F, Fang N, Plum PS, Thieme R, Gockel I, Gromnitza S, Hillmer AM, Chon SH, Schlösser HA, Bruns CJ, Zhao Y. Linking Cancer Stem Cell Plasticity to Therapeutic Resistance-Mechanism and Novel Therapeutic Strategies in Esophageal Cancer. Cells 2020;9:E1481. [PMID: 32560537 DOI: 10.3390/cells9061481] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
197 Lin Y, Zhang X, Wang Y, Zhang J, Liu Q. Single-stranded DNA generated by high temperature accepts protons and builds up mutagenic and carcinogenic strong acids. Mol Biol Rep 2021;48:7633-5. [PMID: 34643928 DOI: 10.1007/s11033-021-06804-0] [Reference Citation Analysis]
198 Li J, Dong G, Song J, Tan G, Wu X. Telomerase inhibition decreases esophageal squamous carcinoma cell migration and invasion. Oncol Lett 2020;20:2870-80. [PMID: 32782603 DOI: 10.3892/ol.2020.11810] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
199 Lacroix O, Couttenier A, Vaes E, Cardwell CR, De Schutter H, Robert A. Statin use after diagnosis is associated with an increased survival in esophageal cancer patients: a Belgian population-based study. Cancer Causes Control 2019;30:385-93. [PMID: 30820714 DOI: 10.1007/s10552-019-01149-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
200 Huang CM, Huang CS, Hsu TN, Huang MS, Fong IH, Lee WH, Liu SC. Disruption of Cancer Metabolic SREBP1/miR-142-5p Suppresses Epithelial-Mesenchymal Transition and Stemness in Esophageal Carcinoma. Cells 2019;9:E7. [PMID: 31861383 DOI: 10.3390/cells9010007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
201 Li J, Wu H, Gao H, Kou R, Xie Y, Zhang Z, Zhang X. TLR4 promoter rs1927914 variant contributes to the susceptibility of esophageal squamous cell carcinoma in the Chinese population. PeerJ 2021;9:e10754. [PMID: 33585082 DOI: 10.7717/peerj.10754] [Reference Citation Analysis]
202 Wang H, Tang H, Fang Y, Tan L, Yin J, Shen Y, Zeng Z, Zhu J, Hou Y, Du M, Jiao J, Jiang H, Gong L, Li Z, Liu J, Xie D, Li W, Lian C, Zhao Q, Chen C, Zheng B, Liao Y, Li K, Li H, Wu H, Dai L, Chen KN. Morbidity and Mortality of Patients Who Underwent Minimally Invasive Esophagectomy After Neoadjuvant Chemoradiotherapy vs Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Randomized Clinical Trial. JAMA Surg 2021;156:444-51. [PMID: 33729467 DOI: 10.1001/jamasurg.2021.0133] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
203 Li Z, Dou L, Zhang Y, He S, Zhao D, Hao C, Song G, Zhang W, Liu Y, Wang G. Characterization of the Oral and Esophageal Microbiota in Esophageal Precancerous Lesions and Squamous Cell Carcinoma. Front Cell Infect Microbiol 2021;11:714162. [PMID: 34604107 DOI: 10.3389/fcimb.2021.714162] [Reference Citation Analysis]
204 Wu Y, Chen X, Liang Y, Li J, Zhang K, Dai L, Guan X, Wang K, Bai Y. Overexpression of long non-coding RNA SOX2OT promotes esophageal squamous cell carcinoma growth. Cancer Cell Int 2018;18:76. [PMID: 29849506 DOI: 10.1186/s12935-018-0570-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
205 Li H, Ding C, Zeng H, Zheng R, Cao M, Ren J, Shi J, Sun D, He S, Yang Z, Yu Y, Zhang Z, Sun X, Guo G, Song G, Wei W, Chen W, He J. Improved esophageal squamous cell carcinoma screening effectiveness by risk-stratified endoscopic screening: evidence from high-risk areas in China. Cancer Commun (Lond) 2021;41:715-25. [PMID: 34146456 DOI: 10.1002/cac2.12186] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
206 Chen X, Jiang J, Zhao Y, Wang X, Zhang C, Zhuan L, Zhang D, Zheng Y. Circular RNA circNTRK2 facilitates the progression of esophageal squamous cell carcinoma through up-regulating NRIP1 expression via miR-140-3p. J Exp Clin Cancer Res 2020;39:133. [PMID: 32653032 DOI: 10.1186/s13046-020-01640-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
207 Zhang Z, Xiong R, Li C, Xu M, Guo M. LncRNA TUG1 promotes cisplatin resistance in esophageal squamous cell carcinoma cells by regulating Nrf2. Acta Biochimica et Biophysica Sinica 2019;51:826-33. [DOI: 10.1093/abbs/gmz069] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 7.7] [Reference Citation Analysis]
208 Sugawara K, Yagi K, Okumura Y, Aikou S, Yamashita H, Seto Y. Survival Prediction Capabilities of Preoperative Inflammatory and Nutritional Status in Esophageal Squamous Cell Carcinoma Patients. World J Surg 2022. [PMID: 34999904 DOI: 10.1007/s00268-021-06398-5] [Reference Citation Analysis]
209 Li J, Liu H, Dong S, Zhang Y, Li X, Wang J. ALKBH5 Is Lowly Expressed in Esophageal Squamous Cell Carcinoma and Inhibits the Malignant Proliferation and Invasion of Tumor Cells. Comput Math Methods Med 2021;2021:1001446. [PMID: 34876920 DOI: 10.1155/2021/1001446] [Reference Citation Analysis]
210 Yang Y, Xu X, Zhou X, Bao W, Zhang D, Gu F, Du X, Chen Q, Qiu G. Impact of Radiation Dose on Survival for Esophageal Squamous Cell Carcinoma Treated With Neoadjuvant Chemoradiotherapy. Front Oncol 2020;10:1431. [PMID: 32974158 DOI: 10.3389/fonc.2020.01431] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
211 Liao G, Wu J, Peng X, Li Y, Tang L, Xu X, Deng D, Zhou X. Visualized analysis of trends and hotspots in global oral microbiome research: A bibliometric study. MedComm (2020) 2020;1:351-61. [PMID: 34766127 DOI: 10.1002/mco2.47] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
212 Yang N, Ying P, Tian J, Wang X, Mei S, Zou D, Peng X, Gong Y, Yang Y, Zhu Y, Ke J, Zhong R, Chang J, Miao X. Genetic variants in m6A modification genes are associated with esophageal squamous-cell carcinoma in the Chinese population. Carcinogenesis 2020;41:761-8. [PMID: 32047883 DOI: 10.1093/carcin/bgaa012] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
213 Shin WJ, Zabel BA, Pachynski RK. Mechanisms and Functions of Chemerin in Cancer: Potential Roles in Therapeutic Intervention. Front Immunol 2018;9:2772. [PMID: 30555465 DOI: 10.3389/fimmu.2018.02772] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
214 Chai T, Shen Z, Zhang Z, Chen S, Gao L, Zhang P, Lin W, Kang M, Lin J. LGR6 is a potential diagnostic and prognostic marker for esophageal squamous cell carcinoma. J Clin Lab Anal 2020;34:e23121. [PMID: 31917882 DOI: 10.1002/jcla.23121] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
215 Codipilly DC, Rubenstein JH, Leggett CL. Whether to screen, or who to screen, that is the question. Gastrointest Endosc 2021:S0016-5107(21)01761-2. [PMID: 34924182 DOI: 10.1016/j.gie.2021.10.024] [Reference Citation Analysis]
216 Munari FF, Dos Santos W, Evangelista AF, Carvalho AC, Pastrez PA, Bugatti D, Wohnrath DR, Scapulatempo-Neto C, Guimarães DP, Longatto-Filho A, Reis RM. Profile of esophageal squamous cell carcinoma mutations in Brazilian patients. Sci Rep 2021;11:20596. [PMID: 34663841 DOI: 10.1038/s41598-021-00208-7] [Reference Citation Analysis]
217 Yang L, Sun K, Chu J, Qu Y, Zhao X, Yin H, Ming L, Wan J, He F. Long non-coding RNA FTH1P3 regulated metastasis and invasion of esophageal squamous cell carcinoma through SP1/NF-kB pathway. Biomed Pharmacother 2018;106:1570-7. [PMID: 30119232 DOI: 10.1016/j.biopha.2018.07.129] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
218 Li C, Zhao S, Zheng Y, Han Y, Chen X, Cheng Z, Wu Y, Feng X, Qi W, Chen K, Xiang J, Li J, Lerut T, Li H. Preoperative pembrolizumab combined with chemoradiotherapy for oesophageal squamous cell carcinoma (PALACE-1). Eur J Cancer 2021;144:232-41. [PMID: 33373868 DOI: 10.1016/j.ejca.2020.11.039] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
219 Yang S, Varghese AM, Sood N, Chiattone C, Akinola NO, Huang X, Gale RP. Ethnic and geographic diversity of chronic lymphocytic leukaemia. Leukemia 2021;35:433-9. [PMID: 33077870 DOI: 10.1038/s41375-020-01057-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
220 Gao C, Wei J, Tang T, Huang Z. Role of microRNA-33a in malignant cells. Oncol Lett 2020;20:2537-56. [PMID: 32782572 DOI: 10.3892/ol.2020.11835] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
221 Wu LL, Wang JL, Huang W, Liu X, Huang YY, Zeng J, Cui CY, Lu JB, Lin P, Long H, Zhang LJ, Wei J, Lu Y, Ma GW. Prognostic Modeling of Patients Undergoing Surgery Alone for Esophageal Squamous Cell Carcinoma: A Histopathological and Computed Tomography Based Quantitative Analysis. Front Oncol 2021;11:565755. [PMID: 33912439 DOI: 10.3389/fonc.2021.565755] [Reference Citation Analysis]
222 Zhou M, Mao Y, Yu S, Li Y, Yin R, Zhang Q, Lu T, Sun R, Lin S, Qian Y, Xu Y, Fan H. LINC00673 Represses CDKN2C and Promotes the Proliferation of Esophageal Squamous Cell Carcinoma Cells by EZH2-Mediated H3K27 Trimethylation. Front Oncol 2020;10:1546. [PMID: 33014799 DOI: 10.3389/fonc.2020.01546] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
223 Shen Y, Xie S, Zhao L, Song G, Shao Y, Hao C, Niu C, Ruan X, Zang Z, Nakyeyune R, Liu F, Wei W. Estimating Individualized Absolute Risk for Esophageal Squamous Cell Carcinoma: A Population-Based Study in High-Risk Areas of China. Front Oncol 2020;10:598603. [PMID: 33489898 DOI: 10.3389/fonc.2020.598603] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
224 Álvarez C, Quiroz A, Benítez-Riquelme D, Riffo E, Castro AF, Pincheira R. SALL Proteins; Common and Antagonistic Roles in Cancer. Cancers (Basel) 2021;13:6292. [PMID: 34944911 DOI: 10.3390/cancers13246292] [Reference Citation Analysis]
225 Oliveira MM, Silva IPB, Teixeira R, Malta DC, Iser BPM. ESOPHAGEAL CANCER MORTALITY IN BRAZIL: A TIME-SERIES ANALYSIS FROM THE GLOBAL BURDEN OF DISEASE STUDY. Arq Gastroenterol 2021;58:100-6. [PMID: 33909787 DOI: 10.1590/S0004-2803.202100000-17] [Reference Citation Analysis]
226 Xie SH, Lagergren J. Risk factors for oesophageal cancer. Best Pract Res Clin Gastroenterol. 2018;36-37:3-8. [PMID: 30551854 DOI: 10.1016/j.bpg.2018.11.008] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
227 Gao J, Tang T, Zhang B, Li G. A Prognostic Signature Based on Immunogenomic Profiling Offers Guidance for Esophageal Squamous Cell Cancer Treatment. Front Oncol 2021;11:603634. [PMID: 33718151 DOI: 10.3389/fonc.2021.603634] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
228 Xu P, Zhang Y, Ge F, Zhang F, He X, Gao X. Modulation of Tumor Microenvironment to Enhance Radiotherapy Efficacy in Esophageal Squamous Cell Carcinoma by Inhibiting Carbonic Anhydrase IX. Front Oncol 2021;11:637252. [PMID: 34249682 DOI: 10.3389/fonc.2021.637252] [Reference Citation Analysis]
229 Li J, Mei X, Sun D, Guo M, Xie M, Chen X. A Nutrition and Inflammation-Related Nomogram to Predict Overall Survival in Surgically Resected Esophageal Squamous Cell Carcinoma (ESCC) Patients. Nutr Cancer 2021;:1-11. [PMID: 34369223 DOI: 10.1080/01635581.2021.1957131] [Reference Citation Analysis]
230 Lin D, Chen X, Tan L. The predictive value of microRNAs for pathological response after neoadjuvant treatment in esophageal squamous cell carcinoma: a systematic review. Ann Transl Med 2021;9:420. [PMID: 33842641 DOI: 10.21037/atm-20-3000] [Reference Citation Analysis]
231 Ji Q, Cai Y, Shrestha SM, Shen D, Zhao W, Shi R. Construction and Validation of an Immune-Related Gene Prognostic Index for Esophageal Squamous Cell Carcinoma. Biomed Res Int 2021;2021:7430315. [PMID: 34722771 DOI: 10.1155/2021/7430315] [Reference Citation Analysis]
232 Qian X, Zhang D, Cao Z, Ma H. Dopamine Pathway Mediated by DRD5 Facilitates Tumor Growth via Enhancing Warburg Effect in Esophageal Cancer. Front Oncol 2021;11:655861. [PMID: 33898321 DOI: 10.3389/fonc.2021.655861] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
233 Lam AK. Introduction: Esophageal Squamous Cell Carcinoma-Current Status and Future Advances. Methods Mol Biol 2020;2129:1-6. [PMID: 32056165 DOI: 10.1007/978-1-0716-0377-2_1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
234 Shimizu D, Koike M, Kanda M, Sonohara F, Hattori N, Hayashi M, Tanaka C, Yamada S, Kodera Y. Newly developed primary malignancies in long-term survivors who underwent curative esophagectomy for squamous cell carcinoma of the esophagus. Surg Today 2021;51:153-8. [PMID: 32638131 DOI: 10.1007/s00595-020-02072-w] [Reference Citation Analysis]
235 Tsukamoto M, Naito M, Wakai K, Naito T, Kojima M, Umemura O, Yokota M, Hanada N, Kawamura T. Tooth brushing, tooth loss, and risk of upper aerodigestive tract cancer: a cohort study of Japanese dentisits. Nagoya J Med Sci 2021;83:331-41. [PMID: 34239181 DOI: 10.18999/nagjms.83.2.331] [Reference Citation Analysis]
236 Yeom JG, Kim JH, Kim JW, Cho Y, Lee IJ, Lee CG, Chun J, Youn YH, Park H. Prognostic Significance of Interim Response Evaluation during Definitive Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma. Cancers (Basel) 2021;13:1255. [PMID: 33809157 DOI: 10.3390/cancers13061255] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
237 Wang J, Ling R, Zhou Y, Gao X, Yang Y, Mao C, Chen D. SREBP1 silencing inhibits the proliferation and motility of human esophageal squamous carcinoma cells via the Wnt/β-catenin signaling pathway. Oncol Lett 2020;20:2855-69. [PMID: 32765792 DOI: 10.3892/ol.2020.11853] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
238 Chu L, Chen Y, Liu Q, Liang F, Wang S, Liu Q, Yu H, Wu X, Zhang J, Deng J, Ai D, Zhu Z, Nie Y, Zhao K. A Phase II Study of Apatinib in Patients with Chemotherapy-Refractory Esophageal Squamous Cell Carcinoma (ESO-Shanghai 11). Oncologist 2021;26:e925-35. [PMID: 33393167 DOI: 10.1002/onco.13668] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
239 Wei M, Zhao L, Lv J, Li X, Zhou G, Fan B, Shen X, Zhao D, Xue F, Wang J, Zhang T. The mediation effect of serum metabolites on the relationship between long-term smoking exposure and esophageal squamous cell carcinoma. BMC Cancer 2021;21:415. [PMID: 33858379 DOI: 10.1186/s12885-021-08151-6] [Reference Citation Analysis]
240 Zhu H, Du F, Cao C. Restoration of circPSMC3 sensitizes gefitinib-resistant esophageal squamous cell carcinoma cells to gefitinib by regulating miR-10a-5p/PTEN axis. Cell Biol Int 2021;45:107-16. [PMID: 32997362 DOI: 10.1002/cbin.11473] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
241 Overwater A, van Munster SN, Offerhaus GJA, Seldenrijk CA, Raicu GM, Koch AD, Bergman JJGHM, Pouw RE, Brosens LAA, Jansen M, Weusten BLAM. Extension of early esophageal squamous cell neoplasia into ducts and submucosal glands and the role of endoscopic ablation therapy. Gastrointest Endosc 2021:S0016-5107(21)01338-9. [PMID: 33974941 DOI: 10.1016/j.gie.2021.04.028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
242 Okello S, Akello SJ, Dwomoh E, Byaruhanga E, Opio CK, Zhang R, Corey KE, Muyindike WR, Ocama P, Christiani DD. Biomass fuel as a risk factor for esophageal squamous cell carcinoma: a systematic review and meta-analysis. Environ Health 2019;18:60. [PMID: 31262333 DOI: 10.1186/s12940-019-0496-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
243 Chen Y, Lu Y, Ren Y, Yuan J, Zhang N, Kimball H, Zhou L, Yang M. Starvation-induced suppression of DAZAP1 by miR-10b integrates splicing control into TSC2-regulated oncogenic autophagy in esophageal squamous cell carcinoma. Theranostics 2020;10:4983-96. [PMID: 32308763 DOI: 10.7150/thno.43046] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
244 Zhang S, Liao W, Wu Q, Huang X, Pan Z, Chen W, Gu S, Huang Z, Wang Y, Tang X, Liang S, Zhang X, Chen Y, Chen S, Chen W, Jiang Y, Chen C, Qiu G. LINC00152 upregulates ZEB1 expression and enhances epithelial-mesenchymal transition and oxaliplatin resistance in esophageal cancer by interacting with EZH2. Cancer Cell Int 2020;20:569. [PMID: 33292221 DOI: 10.1186/s12935-020-01620-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
245 Hryniewicz-Jankowska A, Wierzbicki J, Tabola R, Stach K, Sossey-Alaoui K, Augoff K. The Effect of Neddylation Inhibition on Inflammation-Induced MMP9 Gene Expression in Esophageal Squamous Cell Carcinoma. Int J Mol Sci 2021;22:1716. [PMID: 33572115 DOI: 10.3390/ijms22041716] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
246 Li H, Sun D, Cao M, He S, Zheng Y, Yu X, Wu Z, Lei L, Peng J, Li J, Li N, Chen W. Risk prediction models for esophageal cancer: A systematic review and critical appraisal. Cancer Med 2021;10:7265-76. [PMID: 34414682 DOI: 10.1002/cam4.4226] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
247 Yu-Jing T, Wen-Jing T, Biao T. Integrated Analysis of Hub Genes and Pathways In Esophageal Carcinoma Based on NCBI's Gene Expression Omnibus (GEO) Database: A Bioinformatics Analysis. Med Sci Monit 2020;26:e923934. [PMID: 32756534 DOI: 10.12659/MSM.923934] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
248 Islami F, Poustchi H, Pourshams A, Khoshnia M, Gharavi A, Kamangar F, Dawsey SM, Abnet CC, Brennan P, Sheikh M, Sotoudeh M, Nikmanesh A, Merat S, Etemadi A, Nasseri Moghaddam S, Pharoah PD, Ponder BA, Day NE, Jemal A, Boffetta P, Malekzadeh R. A prospective study of tea drinking temperature and risk of esophageal squamous cell carcinoma. Int J Cancer 2020;146:18-25. [PMID: 30891750 DOI: 10.1002/ijc.32220] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 9.7] [Reference Citation Analysis]
249 Cotton CC, Choksi YA. Lack of Iodine Staining Lugol's Chromoendoscopy Predicts Squamous Neoplastic Progression in a High-risk Region of China: Implications for East and West. Clin Gastroenterol Hepatol 2020;18:1439-41. [PMID: 31712079 DOI: 10.1016/j.cgh.2019.11.008] [Reference Citation Analysis]
250 Feng Z, Qu J, Liu X, Liang J, Li Y, Jiang J, Zhang H, Tian H. Integrated bioinformatics analysis of differentially expressed genes and immune cell infiltration characteristics in Esophageal Squamous cell carcinoma. Sci Rep 2021;11:16696. [PMID: 34404882 DOI: 10.1038/s41598-021-96274-y] [Reference Citation Analysis]
251 Onozato Y, Sasaki Y, Abe Y, Sato H, Yagi M, Mizumoto N, Kon T, Sakai T, Ito M, Umehara M, Koseki A, Ueno Y. Novel genomic alteration in superficial esophageal squamous cell neoplasms in non-smoker non-drinker females. Sci Rep 2021;11:20150. [PMID: 34635759 DOI: 10.1038/s41598-021-99790-z] [Reference Citation Analysis]
252 Zhang J, Xiao F, Qiang G, Zhang Z, Ma Q, Hao Y, Xing H, Liang C. Novel lncRNA Panel as for Prognosis in Esophageal Squamous Cell Carcinoma Based on ceRNA Network Mechanism. Comput Math Methods Med 2021;2021:8020879. [PMID: 34603485 DOI: 10.1155/2021/8020879] [Reference Citation Analysis]
253 Yang YM, Hong P, Xu WW, He QY, Li B. Advances in targeted therapy for esophageal cancer. Signal Transduct Target Ther 2020;5:229. [PMID: 33028804 DOI: 10.1038/s41392-020-00323-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
254 Chen Z, Yao N, Gu H, Song Y, Ye Z, Li L, Lu P, Shao Q. Circular RNA_LARP4 Sponges miR-1323 and Hampers Progression of Esophageal Squamous Cell Carcinoma Through Modulating PTEN/PI3K/AKT Pathway. Dig Dis Sci 2020;65:2272-83. [PMID: 31897898 DOI: 10.1007/s10620-019-05973-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
255 Yang S, Lin S, Li N, Deng Y, Wang M, Xiang D, Xiang G, Wang S, Ye X, Zheng Y, Yao J, Zhai Z, Wu Y, Hu J, Kang H, Dai Z. Burden, trends, and risk factors of esophageal cancer in China from 1990 to 2017: an up-to-date overview and comparison with those in Japan and South Korea. J Hematol Oncol 2020;13:146. [PMID: 33138852 DOI: 10.1186/s13045-020-00981-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
256 Luo QY, Zhou SN, Pan WT, Sun J, Yang LQ, Zhang L, Qiu MZ, Yang DJ. A multi-kinase inhibitor APG-2449 enhances the antitumor effect of ibrutinib in esophageal squamous cell carcinoma via EGFR/FAK pathway inhibition. Biochem Pharmacol 2021;183:114318. [PMID: 33159967 DOI: 10.1016/j.bcp.2020.114318] [Reference Citation Analysis]
257 Gao P, Liu H, Yang Z, Hui Y, Shi Z, Yang Z, Song M, Yao M, Fan W, Yang J, Hao Y, Fan T. Development of a Novel Highly Spontaneous Metastatic Model of Esophageal Squamous Cell Carcinoma Using Renal Capsule Technology. Onco Targets Ther 2021;14:785-93. [PMID: 33574674 DOI: 10.2147/OTT.S290564] [Reference Citation Analysis]
258 Guo Y, Liu Y, Yang H, Dai N, Zhou F, Yang H, Sun W, Kong J, Yuan X, Gao S. Associations of Porphyromonas gingivalis Infection and Low Beclin1 Expression With Clinicopathological Parameters and Survival of Esophageal Squamous Cell Carcinoma Patients. Pathol Oncol Res 2021;27:1609976. [DOI: 10.3389/pore.2021.1609976] [Reference Citation Analysis]
259 Li Z, Liu Y, Dou L, Zhang Y, He S, Zhao D, Zhang W, Wang G. The effects of smoking and drinking on the oral and esophageal microbiota of healthy people. Ann Transl Med 2021;9:1244. [PMID: 34532381 DOI: 10.21037/atm-21-3264] [Reference Citation Analysis]
260 Fitzgerald RC, Vaezi MF. Esophageal Diseases. Gastroenterology 2018;154:263-6. [PMID: 29274867 DOI: 10.1053/j.gastro.2017.12.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
261 Zheng TL, Li DP, He ZF, Zhao S. miR-145 sensitizes esophageal squamous cell carcinoma to cisplatin through directly inhibiting PI3K/AKT signaling pathway. Cancer Cell Int 2019;19:250. [PMID: 31582906 DOI: 10.1186/s12935-019-0943-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
262 Cao Y, Qin S, Luo S, Li Z, Cheng Y, Fan Y, Sun Y, Yin X, Yuan X, Li W, Liu T, Hsu CH, Lin X, Kim SB, Kojima T, Zhang J, Lee SH, Bai Y, Muro K, Doi T, Bai C, Gu K, Pan HM, Bai L, Yang JW, Cui Y, Lu W, Chen J. Pembrolizumab versus chemotherapy for patients with esophageal squamous cell carcinoma enrolled in the randomized KEYNOTE-181 trial in Asia. ESMO Open 2021;7:100341. [PMID: 34973513 DOI: 10.1016/j.esmoop.2021.100341] [Reference Citation Analysis]
263 Zhao S, Jiang Y, Tian T, Zhao J, Xie Y, Chen X, Lu J, Yang F, Li H, Liu K, Dong Z. Jie Du Tong Ye San Prevents N-Nitrosomethylbenzylamine-Induced Esophageal Carcinogenesis via Inhibition of Inflammation and Proliferation. Evid Based Complement Alternat Med 2019;2019:5752670. [PMID: 31236125 DOI: 10.1155/2019/5752670] [Reference Citation Analysis]
264 Narumiya K, Bollschweiler E, Hölscher AH, Yamamoto M, Drebber U, Alakus H, Metzger R, Warnecke-Eberz U. Different response rates to chemotherapy between Japanese and German esophageal squamous cell carcinoma: patients may be influenced by ERCC1 or ABCB1. Future Oncol 2020;16:2075-87. [PMID: 32611208 DOI: 10.2217/fon-2020-0489] [Reference Citation Analysis]
265 Zhang J, Fa X, Zhang Q. MicroRNA‑206 exerts anti‑oncogenic functions in esophageal squamous cell carcinoma by suppressing the c‑Met/AKT/mTOR pathway. Mol Med Rep 2019;19:1491-500. [PMID: 30569129 DOI: 10.3892/mmr.2018.9775] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
266 Pickens A. Racial Disparities in Esophageal Cancer. Thorac Surg Clin 2022;32:57-65. [PMID: 34801196 DOI: 10.1016/j.thorsurg.2021.09.004] [Reference Citation Analysis]
267 Kanaan C, Lorenzo D, Barret M, Audebourg A, Leblanc S, Chaussade S, Prat F, Terris B. Early esophageal squamous cell carcinoma in a western series is not associated with active HPV infection. Virchows Arch 2020;477:697-704. [PMID: 32524184 DOI: 10.1007/s00428-020-02860-2] [Reference Citation Analysis]
268 Tang P, Tan C, Pang Q, Chi CW, Wang Y, Yuan Z, Huang YC, Chen YJ. Combination of 35-Gene Mutation Profile and Radiotherapy Dosimetry Predicts the Therapeutic Outcome of Definitive Chemoradiation in Patients With Esophageal Squamous Cell Carcinoma. Front Oncol 2021;11:729418. [PMID: 34513706 DOI: 10.3389/fonc.2021.729418] [Reference Citation Analysis]
269 Huang E, Fu J, Yu Q, Xie P, Yang Z, Ji H, Wang L, Luo G, Zhang Y, Li K. CircRNA hsa_circ_0004771 promotes esophageal squamous cell cancer progression via miR-339-5p/CDC25A axis. Epigenomics 2020;12:587-603. [PMID: 32050790 DOI: 10.2217/epi-2019-0404] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
270 Ye L, Lu H, Wu L, Zhang L, Shi H, Wu HM, Tu P, Li M, Wang FY. The clinicopathologic features and prognosis of esophageal neuroendocrine carcinomas: a single-center study of 53 resection cases. BMC Cancer. 2019;19:1234. [PMID: 31852479 DOI: 10.1186/s12885-019-6420-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
271 Wakita A, Motoyama S, Sato Y, Nagaki Y, Fujita H, Terata K, Imai K, Minamiya Y. Verification of the Optimal Interval Before Esophagectomy After Preoperative Neoadjuvant Chemoradiotherapy for Locally Advanced Thoracic Esophageal Cancer. Ann Surg Oncol 2021;28:2101-10. [PMID: 33051740 DOI: 10.1245/s10434-020-09206-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
272 Hosseinpour-Moghadam R, Mehryab F, Torshabi M, Haeri A. Applications of Novel and Nanostructured Drug Delivery Systems for the Treatment of Oral Cavity Diseases. Clin Ther 2021;43:e377-402. [PMID: 34844769 DOI: 10.1016/j.clinthera.2021.10.016] [Reference Citation Analysis]
273 Müller M, Posch F, Kiem D, Barth D, Horvath L, Stotz M, Schaberl-Moser R, Pichler M, Greil R, Jost PJ, Seeber A, Amann A, Schlick K, Gerger A, Riedl JM. Benefit of second-line therapy for advanced esophageal squamous cell carcinoma: a tri-center propensity score analysis. Ther Adv Med Oncol 2021;13:17588359211039930. [PMID: 34616490 DOI: 10.1177/17588359211039930] [Reference Citation Analysis]
274 Wu Z, Shi Y, Ren S, Ju Y, Hu Y, Wu J. ADAMTS8 Inhibits Progression of Esophageal Squamous Cell Carcinoma. DNA Cell Biol 2020. [PMID: 33054388 DOI: 10.1089/dna.2020.6053] [Reference Citation Analysis]
275 Vivaldi C, Catanese S, Massa V, Pecora I, Salani F, Santi S, Lencioni M, Vasile E, Falcone A, Fornaro L. Immune Checkpoint Inhibitors in Esophageal Cancers: are we Finally Finding the Right Path in the Mist? Int J Mol Sci 2020;21:E1658. [PMID: 32121290 DOI: 10.3390/ijms21051658] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
276 Xiao HF, Yan SP, Li JG, Shi ZH, Zou YH, Xu KK, Liao XZ. Development and external validation of a nomogram to predict the risk of Upper gastrointestinal precancerous lesions in a non-high-incidence area. Cancer Med 2020;9:8722-32. [PMID: 32937009 DOI: 10.1002/cam4.3462] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
277 Noh JH, Gong EJ, Kim DH, Na HK, Ahn JY, Lee JH, Jung KW, Choi KD, Song HJ, Lee GH, Jung HY. Endoscopic submucosal dissection for superficial esophageal neoplasms in elderly patients: A single-center, large-scale, retrospective study. Geriatr Gerontol Int 2020;20:430-5. [PMID: 32133752 DOI: 10.1111/ggi.13892] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
278 Teufel A, Quante M, Kandulski A, Hirth M, Zhan T, Eckardt M, Thieme R, Kusnik A, Yesmembetov K, Wiest I, Riemann JF, Schlitt HJ, Gockel I, Malfertheiner P, Ebert MP. [Prevention of gastrointestinal cancer]. Z Gastroenterol 2021;59:964-82. [PMID: 34507375 DOI: 10.1055/a-1540-7539] [Reference Citation Analysis]
279 Yang H, Hu B. Recent advances in early esophageal cancer: diagnosis and treatment based on endoscopy. Postgrad Med 2021;133:665-73. [PMID: 34030580 DOI: 10.1080/00325481.2021.1934495] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
280 Lavery A, Turkington RC. Transcriptomic biomarkers for predicting response to neoadjuvant treatment in oesophageal cancer. Gastroenterol Rep (Oxf) 2020;8:411-24. [PMID: 33442473 DOI: 10.1093/gastro/goaa065] [Reference Citation Analysis]
281 Dekker E, Houwen BBSL, Puig I, Bustamante-balén M, Coron E, Dobru DE, Kuvaev R, Neumann H, Johnson G, Pimentel-nunes P, Sanders DS, Dinis-ribeiro M, Arvanitakis M, Ponchon T, East JE, Bisschops R. Curriculum for optical diagnosis training in Europe: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. Endoscopy 2020;52:899-923. [DOI: 10.1055/a-1231-5123] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
282 Moon H, Zhu J, Donahue LR, Choi E, White AC. Krt5+/Krt15+ foregut basal progenitors give rise to cyclooxygenase-2-dependent tumours in response to gastric acid stress. Nat Commun 2019;10:2225. [PMID: 31110179 DOI: 10.1038/s41467-019-10194-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
283 Du Y, Yan D, Yuan Y, Xu J, Wang S, Yang Z, Cheng W, Tian X, Kan Q. CDK11p110 plays a critical role in the tumorigenicity of esophageal squamous cell carcinoma cells and is a potential drug target. Cell Cycle 2019;18:452-66. [PMID: 30722725 DOI: 10.1080/15384101.2019.1577665] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
284 Sun L, Zhao W, Li J, Tse LA, Xing X, Lin S, Zhao J, Ren Z, Zhang CX, Liu X. Dietary flavonoid intake and risk of esophageal squamous cell carcinoma: A population-based case-control study. Nutrition 2021;89:111235. [PMID: 33878555 DOI: 10.1016/j.nut.2021.111235] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
285 Zhang SY, Qin S, Li GH, Yi YQ, Fu HJ, Gao YJ, Sun ML. Detection of peripheral blood circulating tumor cells in oral squamous cell carcinoma and its clinical significance. Hua Xi Kou Qiang Yi Xue Za Zhi 2021;39:591-7. [PMID: 34636209 DOI: 10.7518/hxkq.2021.05.015] [Reference Citation Analysis]
286 Slawinski CGV, Barriuso J, Guo H, Renehan AG. Obesity and Cancer Treatment Outcomes: Interpreting the Complex Evidence. Clin Oncol (R Coll Radiol) 2020;32:591-608. [PMID: 32595101 DOI: 10.1016/j.clon.2020.05.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
287 Uhlenhopp DJ, Then EO, Sunkara T, Gaduputi V. Epidemiology of esophageal cancer: update in global trends, etiology and risk factors. Clin J Gastroenterol 2020;13:1010-21. [PMID: 32965635 DOI: 10.1007/s12328-020-01237-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 10.5] [Reference Citation Analysis]
288 Yang X, Tian M, Zhang W, Chai T, Shen Z, Kang M, Lin J. Identification of potential core genes in esophageal carcinoma using bioinformatics analysis. Medicine (Baltimore) 2021;100:e26428. [PMID: 34232175 DOI: 10.1097/MD.0000000000026428] [Reference Citation Analysis]
289 Chen Z, Huang Y, Hu Z, Zhao M, Bian Y, Chen Z, Zheng Y, Bi G, Pang Y, Zhan C, Lin Z, Guo W, Wang Q, Tan L. Dissecting the single-cell transcriptome network in patients with esophageal squamous cell carcinoma receiving operative paclitaxel plus platinum chemotherapy. Oncogenesis 2021;10:71. [PMID: 34697289 DOI: 10.1038/s41389-021-00359-2] [Reference Citation Analysis]
290 Shan TT, Zhao X, Zhang Z, Wang JP, Zhang Y, Yang Y, Zhao S. Clinical Significance of Down-Regulated CD70 and CD27 Expression in Poor Prognosis of Esophageal Squamous Cell Carcinoma. Cancer Manag Res 2020;12:6909-20. [PMID: 33204151 DOI: 10.2147/CMAR.S241377] [Reference Citation Analysis]
291 Li P, Jing J, Guo W, Guo X, Hu W, Qi X, Wei WQ, Zhuang G. The associations of air pollution and socioeconomic factors with esophageal cancer in China based on a spatiotemporal analysis. Environ Res 2021;196:110415. [PMID: 33159927 DOI: 10.1016/j.envres.2020.110415] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
292 Yu J, Wu X, Lv M, Zhang Y, Zhang X, Li J, Zhu M, Huang J, Zhang Q. A model for predicting prognosis in patients with esophageal squamous cell carcinoma based on joint representation learning. Oncol Lett 2020;20:387. [PMID: 33193847 DOI: 10.3892/ol.2020.12250] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
293 Fan Y, Wang Y, Fu S, Liu D, Lin S. Methylation-regulated ZNF545 inhibits growth of the p53-mutant KYSE150 cell line by inducing p21 and Bax. Exp Ther Med 2019;18:1563-70. [PMID: 31410110 DOI: 10.3892/etm.2019.7737] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
294 Wang KL, Chen XL, Lei L, Li P, Hong LL, Huang XC, Mao WM, Mukaisho K, Ling ZQ. Validation study of susceptibility loci for esophageal squamous cell carcinoma identified by GWAS in a Han Chinese subgroup from Eastern China. J Cancer 2019;10:3624-31. [PMID: 31333779 DOI: 10.7150/jca.32810] [Reference Citation Analysis]
295 Kawasaki M, Ikeda Y, Ikeda E, Takahashi M, Tanaka D, Nakajima Y, Arakawa S, Izumi Y, Miyake S. Oral infectious bacteria in dental plaque and saliva as risk factors in patients with esophageal cancer. Cancer 2021;127:512-9. [PMID: 33156979 DOI: 10.1002/cncr.33316] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
296 Wang L, Dong G, Xia W, Mao Q, Wang A, Chen B, Ma W, Wu Y, Xu L, Jiang F. Integrative analysis of differential genes and identification of a "2-gene score" associated with survival in esophageal squamous cell carcinoma. Thorac Cancer 2019;10:60-70. [PMID: 30421504 DOI: 10.1111/1759-7714.12902] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
297 Zhihua Z, Weiwei W, Lihua N, Jianying Z, Jiang G. p53-induced long non-coding RNA PGM5-AS1 inhibits the progression of esophageal squamous cell carcinoma through regulating miR-466/PTEN axis. IUBMB Life. 2019;71:1492-1502. [PMID: 31185143 DOI: 10.1002/iub.2069] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
298 Ehrenhöfer-Wölfer K, Puchner T, Schwarz C, Rippka J, Blaha-Ostermann S, Strobl U, Hörmann A, Bader G, Kornigg S, Zahn S, Sommergruber W, Schweifer N, Zichner T, Schlattl A, Neumüller RA, Shi J, Vakoc CR, Kögl M, Petronczki M, Kraut N, Pearson MA, Wöhrle S. SMARCA2-deficiency confers sensitivity to targeted inhibition of SMARCA4 in esophageal squamous cell carcinoma cell lines. Sci Rep 2019;9:11661. [PMID: 31406271 DOI: 10.1038/s41598-019-48152-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
299 Wang SM, Abnet CC, Qiao YL. What have we learned from Linxian esophageal cancer etiological studies? Thorac Cancer 2019;10:1036-42. [PMID: 30925028 DOI: 10.1111/1759-7714.13058] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
300 Zhang J, Luo A, Huang F, Gong T, Liu Z. SERPINE2 promotes esophageal squamous cell carcinoma metastasis by activating BMP4. Cancer Lett 2020;469:390-8. [PMID: 31730904 DOI: 10.1016/j.canlet.2019.11.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
301 Qu F, Wang L, Wang C, Yu L, Zhao K, Zhong H. Circular RNA circ_0006168 enhances Taxol resistance in esophageal squamous cell carcinoma by regulating miR-194-5p/JMJD1C axis. Cancer Cell Int 2021;21:273. [PMID: 34022910 DOI: 10.1186/s12935-021-01984-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
302 Erkizan HV, Sukhadia S, Natarajan TG, Marino G, Notario V, Lichy JH, Wadleigh RG. Exome sequencing identifies novel somatic variants in African American esophageal squamous cell carcinoma. Sci Rep 2021;11:14814. [PMID: 34285259 DOI: 10.1038/s41598-021-94064-0] [Reference Citation Analysis]
303 Maldonado López A, Capell BC. The METTL3-m6A Epitranscriptome: Dynamic Regulator of Epithelial Development, Differentiation, and Cancer. Genes (Basel) 2021;12:1019. [PMID: 34209046 DOI: 10.3390/genes12071019] [Reference Citation Analysis]
304 Lu D, Liu X, Feng S, Dong X, Shi X, Ren P, Diao D, Wu H, Xiong G, Wang H, Li M, Rao S, Molena D, Wu AJ, Cai K. The Current Situation of Esophageal Cancer Staging and Perioperative Strategies Determination in Central and Southern China: A Cross Sectional Survey. Front Oncol 2019;9:1098. [PMID: 31696056 DOI: 10.3389/fonc.2019.01098] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
305 Fang X, Shrestha SM, Ren LH, Shi RH. Biological and clinical implications of metastasis-associated circular RNAs in oesophageal squamous cell carcinoma. FEBS Open Bio 2021;11:2870-87. [PMID: 34510785 DOI: 10.1002/2211-5463.13297] [Reference Citation Analysis]
306 Lu T, Xu R, Li Q, Zhao JY, Peng B, Zhang H, Guo JD, Zhang SQ, Li HW, Wang J, Zhang LY. Systematic profiling of ferroptosis gene signatures predicts prognostic factors in esophageal squamous cell carcinoma. Mol Ther Oncolytics 2021;21:134-43. [PMID: 33981829 DOI: 10.1016/j.omto.2021.02.011] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
307 Wang K, Zhang L, He ZH, Liu ZJ, Zhang L, Hu N, Jin Z, Ke Y, Duan LP. A population-based survey of gastroesophageal reflux disease in a region with high prevalence of esophageal cancer in China. Chin Med J (Engl) 2019;132:1516-23. [PMID: 31045906 DOI: 10.1097/CM9.0000000000000275] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
308 Cheng J, Ma H, Yan M, Xing W. THAP9-AS1/miR-133b/SOX4 positive feedback loop facilitates the progression of esophageal squamous cell carcinoma. Cell Death Dis 2021;12:401. [PMID: 33854048 DOI: 10.1038/s41419-021-03690-z] [Reference Citation Analysis]
309 Xie Z, Li T, Huang B, Liu S, Zhang L, Zhang Q. Semaphorin 3F Serves as a Tumor Suppressor in Esophageal Squamous Cell Carcinoma and is Associated With Lymph Node Metastasis in Disease Progression. Technol Cancer Res Treat 2020;19:1533033820928117. [PMID: 32441221 DOI: 10.1177/1533033820928117] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
310 Huang W, Zhu J, Shi H, Wu Q, Zhang C. ITGA2 Overexpression Promotes Esophageal Squamous Cell Carcinoma Aggression via FAK/AKT Signaling Pathway. Onco Targets Ther 2021;14:3583-96. [PMID: 34113124 DOI: 10.2147/OTT.S302028] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
311 Yang H, Zhang Q, Xu M, Wang L, Chen X, Feng Y, Li Y, Zhang X, Cui W, Jia X. CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis. Mol Cancer 2020;19:41. [PMID: 32103760 DOI: 10.1186/s12943-020-01165-x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 44] [Article Influence: 17.0] [Reference Citation Analysis]
312 Xiao S, Liu N, Yang X, Ji G, Li M. Polygalacin D suppresses esophageal squamous cell carcinoma growth and metastasis through regulating miR-142-5p/Nrf2 axis. Free Radic Biol Med 2021;164:58-75. [PMID: 33307164 DOI: 10.1016/j.freeradbiomed.2020.11.029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
313 Moon H, White AC, Borowsky AD. New insights into the functions of Cox-2 in skin and esophageal malignancies. Exp Mol Med 2020;52:538-47. [PMID: 32235869 DOI: 10.1038/s12276-020-0412-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
314 Ma Y, He S, Gao A, Zhang Y, Zhu Q, Wang P, Yang B, Yin H, Li Y, Song J, Yue P, Li M, Zhang D, Liu Y, Wang X, Guo M, Jiao Y. Methylation silencing of TGF-β receptor type II is involved in malignant transformation of esophageal squamous cell carcinoma. Clin Epigenetics 2020;12:25. [PMID: 32046777 DOI: 10.1186/s13148-020-0819-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
315 Chen WS, Zhu LH, Li WJ, Tu PJ, Huang JY, You PL, Pan XJ. Novel technique for lymphadenectomy along left recurrent laryngeal nerve during thoracoscopic esophagectomy. World J Gastroenterol 2020; 26(12): 1340-1351 [PMID: 32256021 DOI: 10.3748/wjg.v26.i12.1340] [Cited by in CrossRef: 1] [Article Influence: 0.5] [Reference Citation Analysis]
316 Kahn A, Crowell MD, Fleischer DE. Reducing the risk of esophageal squamous cell carcinoma: out with the old; in with the new. Gastrointest Endosc 2019;89:733-5. [PMID: 30902201 DOI: 10.1016/j.gie.2018.12.017] [Reference Citation Analysis]
317 El Jaddaoui I, Allali I, Sehli S, Ouldim K, Hamdi S, Al Idrissi N, Nejjari C, Amzazi S, Bakri Y, Ghazal H. Cancer Omics in Africa: Present and Prospects. Front Oncol 2020;10:606428. [PMID: 33425763 DOI: 10.3389/fonc.2020.606428] [Reference Citation Analysis]
318 Wang WW, Zhao ZH, Wang L, Li P, Chen KS, Zhang JY, Li WC, Jiang GZ, Li XN. MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway. EBioMedicine 2019;46:66-78. [PMID: 31383552 DOI: 10.1016/j.ebiom.2019.07.050] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
319 Zhang SW, Wu LL, Yang H, Li CZ, Wei WJ, Wang M, Ma GW, Zhong JD. Effect of the Active Cycle of Breathing Technique on Perioperative Outcome in Individuals With Esophagectomy: A Quasi-Experimental Study. Front Surg 2021;8:735947. [PMID: 34722622 DOI: 10.3389/fsurg.2021.735947] [Reference Citation Analysis]
320 Lim CH, Park YJ, Shin M, Cho YS, Choi JY, Lee KH, Hyun SH. Tumor SUVs on 18F-FDG PET/CT and Aggressive Pathological Features in Esophageal Squamous Cell Carcinoma. Clin Nucl Med 2020;45:e128-33. [PMID: 31977480 DOI: 10.1097/RLU.0000000000002926] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
321 Dai SL, Wei SS, Zhang C, Li XY, Liu YP, Ma M, Lv HL, Zhang Z, Zhao LM, Shan BE. MTA2 promotes the metastasis of esophageal squamous cell carcinoma via EIF4E-Twist feedback loop. Cancer Sci 2021;112:1060-74. [PMID: 33340431 DOI: 10.1111/cas.14778] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
322 Stachler MD, Jin RU. Molecular Pathology of Gastroesophageal Cancer. Surg Pathol Clin 2021;14:443-53. [PMID: 34373095 DOI: 10.1016/j.path.2021.05.008] [Reference Citation Analysis]
323 Cui C, Dong H, Ren H, Lin G, Zhao L. Characterization of Esophageal Cancer and ItsAssociation with Influencing Factors in GuangzhouCity, China. Int J Environ Res Public Health 2020;17:E1498. [PMID: 32110940 DOI: 10.3390/ijerph17051498] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
324 Noguera E, Sorribas M, Admella V, Biondo S. Oral health and gastrointestinal neoplasia: Narrative review. Cir Esp (Engl Ed) 2021;99:716-23. [PMID: 34776408 DOI: 10.1016/j.cireng.2021.11.002] [Reference Citation Analysis]
325 Mushi BP, Mwachiro MM, Buckle G, Kaimila BN, Mulima G, Kayamba V, Kelly P, Akoko L, Mmbaga EJ, Selekwa M, Ringo Y, Pritchett N, White RE, Topazian MD, Fleischer DE, Dawsey SM, Van Loon K. Improving Access to Self-Expanding Metal Stents for Patients With Esophageal Cancer in Eastern Africa: A Stepwise Implementation Strategy. JCO Glob Oncol 2021;7:118-26. [PMID: 33449802 DOI: 10.1200/GO.20.00318] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
326 Song G, Lu Y, Tang L, Li M, Yin J, Chen H, Ling J. (-)-4-O-(4-O-β-D-glucopyranosylcaffeoyl) quinic acid enhanced the efficacy of anti-PD-L1 against esophageal carcinoma through inhibiting PI3K pathway. Immunopharmacol Immunotoxicol 2021;43:806-12. [PMID: 34694960 DOI: 10.1080/08923973.2021.1990315] [Reference Citation Analysis]
327 Vanella G, Archibugi L, Stigliano S, Capurso G. Alcohol and gastrointestinal cancers. Current Opinion in Gastroenterology 2019;35:107-13. [DOI: 10.1097/mog.0000000000000502] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
328 Gao Y, Xin L, Feng YD, Yao B, Lin H, Sun C, An W, Li ZS, Shi RH, Wang LW. Feasibility and Accuracy of Artificial Intelligence-Assisted Sponge Cytology for Community-Based Esophageal Squamous Cell Carcinoma Screening in China. Am J Gastroenterol 2021;116:2207-15. [PMID: 34546186 DOI: 10.14309/ajg.0000000000001499] [Reference Citation Analysis]
329 Wang H, Li H, Yu Y, Jiang Q, Zhang R, Sun H, Xing W, Li Y. Long non-coding RNA XIST promotes the progression of esophageal squamous cell carcinoma through sponging miR-129-5p and upregulating CCND1 expression. Cell Cycle 2021;20:39-53. [PMID: 33345719 DOI: 10.1080/15384101.2020.1856497] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
330 Liu AQ, Vogtmann E, Shao DT, Abnet CC, Dou HY, Qin Y, Su Z, Wei WQ, Chen W. A Comparison of Biopsy and Mucosal Swab Specimens for Examining the Microbiota of Upper Gastrointestinal Carcinoma. Cancer Epidemiol Biomarkers Prev 2019;28:2030-7. [PMID: 31519703 DOI: 10.1158/1055-9965.EPI-18-1210] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
331 Sun F, Zhang C, Ma D, Wang K. MicroRNA-544 inhibits esophageal squamous cell carcinoma cell proliferation and enhances sensitivity to cisplatin by repressing E2F transcription factor 5. Oncol Lett 2019;18:4203-9. [PMID: 31579422 DOI: 10.3892/ol.2019.10749] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
332 Niu C, Zhao L, Guo X, Shen Y, Shao Y, Liu F. Diagnostic Accuracy of circRNAs in Esophageal Cancer: A Meta-Analysis. Dis Markers 2019;2019:9673129. [PMID: 31534563 DOI: 10.1155/2019/9673129] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
333 Pan D, Su M, Huang G, Luo P, Zhang T, Fu L, Wei J, Wang S, Sun G. MTHFR C677T genetic polymorphism in combination with serum vitamin B2, B12 and aberrant DNA methylation of P16 and P53 genes in esophageal squamous cell carcinoma and esophageal precancerous lesions: a case-control study. Cancer Cell Int 2019;19:288. [PMID: 31754346 DOI: 10.1186/s12935-019-1012-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
334 Lichtenberger JP 3rd, Zeman MN, Dulberger AR, Alqutub S, Carter BW, Manning MA. Esophageal Neoplasms: Radiologic-Pathologic Correlation. Radiol Clin North Am 2021;59:205-17. [PMID: 33551082 DOI: 10.1016/j.rcl.2020.11.002] [Reference Citation Analysis]
335 Li MY, Fan LN, Han DH, Yu Z, Ma J, Liu YX, Li PF, Zhao DH, Chai J, Jiang L, Li SL, Xiao JJ, Duan QH, Ye J, Shi M, Nie YZ, Wu KC, Liao DJ, Shi Y, Wang Y, Yan QG, Guo SP, Bian XW, Zhu F, Zhang J, Wang Z. Ribosomal S6 protein kinase 4 promotes radioresistance in esophageal squamous cell carcinoma. J Clin Invest 2020;130:4301-19. [PMID: 32396532 DOI: 10.1172/JCI134930] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
336 Mei LX, Mo JX, Chen Y, Dai L, Wang YY, Chen MW. Esophagectomy versus definitive chemoradiotherapy as initial treatment for clinical stage I esophageal cancer: a systematic review and meta-analysis. Dis Esophagus 2021:doab049. [PMID: 34318324 DOI: 10.1093/dote/doab049] [Reference Citation Analysis]
337 Cameniţă D, Demetrian AD, Pleşea RM, Tănasie-Vasile MI, Strâmbu VDE, Grigorean VT, Ioniţă E, Pleşea IE, Marincaş AM. Clinical-morphological profiles of esophageal carcinoma's main types. Rom J Morphol Embryol 2020;61:407-22. [PMID: 33544792 DOI: 10.47162/RJME.61.2.10] [Reference Citation Analysis]
338 Ferndale L, Aldous C, Hift R, Thomson S. Gender Differences in Oesophageal Squamous Cell Carcinoma in a South African Tertiary Hospital. Int J Environ Res Public Health 2020;17:E7086. [PMID: 32998198 DOI: 10.3390/ijerph17197086] [Reference Citation Analysis]
339 Cai Z, Liu Q. Understanding the Global Cancer Statistics 2018: implications for cancer control. Sci China Life Sci 2021;64:1017-20. [PMID: 31463738 DOI: 10.1007/s11427-019-9816-1] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 12.3] [Reference Citation Analysis]
340 Newberry C, Lynch K. Using Diet to Treat Diseases of Esophagus: Back to the Basics. Gastroenterol Clin North Am 2021;50:959-72. [PMID: 34717881 DOI: 10.1016/j.gtc.2021.08.008] [Reference Citation Analysis]
341 Mwachiro MM, Pritchett N, Calafat AM, Parker RK, Lando JO, Murphy G, Chepkwony R, Burgert SL, Abnet CC, Topazian MD, White RE, Dawsey SM, Etemadi A. Indoor wood combustion, carcinogenic exposure and esophageal cancer in southwest Kenya. Environ Int 2021;152:106485. [PMID: 33689906 DOI: 10.1016/j.envint.2021.106485] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
342 Li J, Han X, Gu Y, Wu J, Song J, Shi Z, Chang H, Liu M, Zhang Y. LncRNA MTX2-6 Suppresses Cell Proliferation by Acting as ceRNA of miR-574-5p to Accumulate SMAD4 in Esophageal Squamous Cell Carcinoma. Front Cell Dev Biol 2021;9:654746. [PMID: 33869216 DOI: 10.3389/fcell.2021.654746] [Reference Citation Analysis]
343 Zeng X, Li L, Wang W, Zhu L. Rehabilitation Nursing Intervention Can Improve Dysphagia and Quality of Life of Patients Undergoing Radiotherapy for Esophageal Cancer. J Oncol 2021;2021:3711699. [PMID: 34394350 DOI: 10.1155/2021/3711699] [Reference Citation Analysis]
344 Fahey PP, Page A, Stone G, Astell-Burt T. Augmenting cancer registry data with health survey data with no cases in common: the relationship between pre-diagnosis health behaviour and post-diagnosis survival in oesophageal cancer. BMC Cancer 2020;20:496. [PMID: 32487049 DOI: 10.1186/s12885-020-06990-3] [Reference Citation Analysis]
345 Zheng W, Chen C, Yu J, Jin C, Han T. An energy metabolism-based eight-gene signature correlates with the clinical outcome of esophagus carcinoma. BMC Cancer 2021;21:345. [PMID: 33794814 DOI: 10.1186/s12885-021-08030-0] [Reference Citation Analysis]
346 Wu C, Huang H, Choi HY, Ma Y, Zhou T, Peng Y, Pang K, Shu G, Yang X. Anti-esophageal Cancer Effect of Corilagin Extracted from Phmllanthi Fructus via the Mitochondrial and Endoplasmic Reticulum Stress Pathways. J Ethnopharmacol 2021;269:113700. [PMID: 33346026 DOI: 10.1016/j.jep.2020.113700] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
347 Zhou C, Ma J, Lu Y, Zhao W, Xu B, Lin J, Ma Y, Tian Y, Zhang Q, Wang W, Yan W, Jiao P. TERT promoter regulating melittin expression induces apoptosis and G0/G1 cell cycle arrest in esophageal carcinoma cells. Oncol Lett 2021;21:16. [PMID: 33240422 DOI: 10.3892/ol.2020.12277] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
348 Pan D, Wang S, Su M, Sun G, Zhu X, Ghahvechi Chaeipeima M, Guo Z, Wang N, Zhang Z, Cui M. Vitamin B12 may play a preventive role in esophageal precancerous lesions: a case-control study based on markers in blood and 3-day duplicate diet samples. Eur J Nutr 2021;60:3375-86. [PMID: 33619628 DOI: 10.1007/s00394-021-02516-0] [Reference Citation Analysis]
349 Cronin-Fenton D. A burning question: does hot green tea drinking increase the risk of esophageal squamous cell carcinoma? Clin Epidemiol 2018;10:1321-3. [PMID: 30310325 DOI: 10.2147/CLEP.S183480] [Reference Citation Analysis]
350 Wang J, Wu D, Zhang J, Liu H, Wu J, Dong W. α-Hederin Induces Apoptosis of Esophageal Squamous Cell Carcinoma via an Oxidative and Mitochondrial-Dependent Pathway. Dig Dis Sci 2019;64:3528-38. [PMID: 31273592 DOI: 10.1007/s10620-019-05689-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
351 Yamamoto S, Kawakami H, Kii T, Hara H, Kawabata R, Kawada J, Takeno A, Matsuyama J, Ueda S, Okita Y, Endo S, Kimura Y, Yanagihara K, Okuno T, Kurokawa Y, Shimokawa T, Satoh T. Randomized phase II study of docetaxel versus paclitaxel in patients with esophageal squamous cell carcinoma refractory to fluoropyrimidine- and platinum-based chemotherapy: OGSG1201. Eur J Cancer 2021;154:307-15. [PMID: 34311300 DOI: 10.1016/j.ejca.2021.06.035] [Reference Citation Analysis]
352 Ye L, Zhang J, Zhang Y, Gu B, Zhu H, Mao X. Isoliquiritigenin Suppressed Esophageal Squamous Carcinoma Growth by Blocking EGFR Activation and Inducing Cell Cycle Arrest. Biomed Res Int 2020;2020:9259852. [PMID: 32190688 DOI: 10.1155/2020/9259852] [Reference Citation Analysis]
353 Bian Y, Bi G, Wei T, Yao G, Chen Z, Zhan C, Fan H. Integrative genome-scale analysis of immune infiltration in esophageal carcinoma. Int Immunopharmacol 2021;93:107371. [PMID: 33535118 DOI: 10.1016/j.intimp.2021.107371] [Reference Citation Analysis]
354 Yang YL, Li ZQ, Wang QL, Gu JJ, Fang XJ, Huang GH. Efficacy and Safety of Programmed Cell Death 1 Inhibitor Monotherapy Versus Chemotherapy as Second-Line Treatment for Advanced Esophageal Cancer: A Meta-analysis and Systematic Review. Clin Ther 2021:S0149-2918(21)00391-X. [PMID: 34794831 DOI: 10.1016/j.clinthera.2021.09.018] [Reference Citation Analysis]
355 Dua KS, Sasikala M. Repairing the human esophagus with tissue engineering. Gastrointestinal Endoscopy 2018;88:579-88. [DOI: 10.1016/j.gie.2018.06.032] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
356 Mitani S, Kadowaki S, Oze I, Masuishi T, Narita Y, Bando H, Oonishi S, Hirayama Y, Tanaka T, Tajika M, Koide Y, Kodaira T, Abe T, Muro K. Risk of second primary malignancies after definitive treatment for esophageal cancer: A competing risk analysis. Cancer Med 2020;9:394-400. [PMID: 31730285 DOI: 10.1002/cam4.2688] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
357 Li D, Zhang L, Liu Y, Sun H, Onwuka JU, Zhao Z, Tian W, Xu J, Zhao Y, Xu H. Specific DNA methylation markers in the diagnosis and prognosis of esophageal cancer. Aging (Albany NY) 2019;11:11640-58. [PMID: 31834866 DOI: 10.18632/aging.102569] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
358 Tang D, Wang L, Jiang J, Liu Y, Ni M, Fu Y, Guo H, Wang Z, An F, Zhang K, Hu Y, Zhan Q, Xu G, Zou X. A Novel Deep Learning System for Diagnosing Early Esophageal Squamous Cell Carcinoma: A Multicenter Diagnostic Study. Clin Transl Gastroenterol 2021;12:e00393. [PMID: 34346911 DOI: 10.14309/ctg.0000000000000393] [Reference Citation Analysis]
359 Su JF, Zhao F, Gao ZW, Hou YJ, Li YY, Duan LJ, Lun SM, Yang HJ, Li JK, Dai NT, Shen FF, Zhou FY. piR-823 demonstrates tumor oncogenic activity in esophageal squamous cell carcinoma through DNA methylation induction via DNA methyltransferase 3B. Pathol Res Pract 2020;216:152848. [PMID: 32051106 DOI: 10.1016/j.prp.2020.152848] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
360 Lee A, Khulusi S, Watson R. Gastroesophageal cancer patients need earlier palliative intervention - Using data to inform appropriate care. Eur J Oncol Nurs. 2019;40:126-130. [PMID: 31229202 DOI: 10.1016/j.ejon.2019.04.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
361 Hirose T, Yamamoto S, Kato K. Emerging data on nivolumab for esophageal squamous cell carcinoma. Expert Rev Gastroenterol Hepatol 2021;15:845-54. [PMID: 34251958 DOI: 10.1080/17474124.2021.1948836] [Reference Citation Analysis]
362 Zhao C, Lu Q, Gu Y, Pan E, Sun Z, Zhang H, Zhou J, Du Y, Zhang Y, Feng Y, Liu R, Pu Y, Yin L. Distribution of N-nitrosamines in drinking water and human urinary excretions in high incidence area of esophageal cancer in Huai'an, China. Chemosphere 2019;235:288-96. [DOI: 10.1016/j.chemosphere.2019.06.124] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
363 Yang N, Tian J, Wang X, Mei S, Zou D, Peng X, Zhu Y, Yang Y, Gong Y, Ke J, Zhong R, Chang J, Miao X. A functional variant in TNXB promoter associates with the risk of esophageal squamous-cell carcinoma. Mol Carcinog 2020;59:439-46. [PMID: 32056283 DOI: 10.1002/mc.23166] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
364 Kwak AW, Choi JS, Lee MH, Oh HN, Cho SS, Yoon G, Liu K, Chae JI, Shim JH. Retrochalcone Echinatin Triggers Apoptosis of Esophageal Squamous Cell Carcinoma via ROS- and ER Stress-Mediated Signaling Pathways. Molecules 2019;24:E4055. [PMID: 31717502 DOI: 10.3390/molecules24224055] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
365 Alaouna M, Hull R, Penny C, Dlamini Z. Esophageal cancer genetics in South Africa. Clin Exp Gastroenterol 2019;12:157-77. [PMID: 31114287 DOI: 10.2147/CEG.S182000] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
366 Zhuang H, Wang H, Yang H, Li H. Exosome-Encapsulated MicroRNA-21 from Esophageal Squamous Cell Carcinoma Cells Enhances Angiogenesis of Human Umbilical Venous Endothelial Cells by Targeting SPRY1. Cancer Manag Res 2020;12:10651-67. [PMID: 33149673 DOI: 10.2147/CMAR.S259077] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
367 Liu Z, Gu S, Wu K, Li L, Dong C, Wang W, Zhou Y. CircRNA-DOPEY2 enhances the chemosensitivity of esophageal cancer cells by inhibiting CPEB4-mediated Mcl-1 translation. J Exp Clin Cancer Res 2021;40:361. [PMID: 34781999 DOI: 10.1186/s13046-021-02149-5] [Reference Citation Analysis]
368 Liu B, Li X, Li C, Xu R, Sun X. miR-25 mediates metastasis and epithelial-mesenchymal-transition in human esophageal squamous cell carcinoma via regulation of E-cadherin signaling. Bioengineered. 2019;10:679-688. [PMID: 31679450 DOI: 10.1080/21655979.2019.1687391] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
369 Shen Z, Chai T, Luo F, Liu Z, Xu H, Zhang P, Kang M, Chen S. Loss of miR-204-5p Promotes Tumor Proliferation, Migration, and Invasion Through Targeting YWHAZ/PI3K/AKT Pathway in Esophageal Squamous Cell Carcinoma. Onco Targets Ther 2020;13:4679-90. [PMID: 32547097 DOI: 10.2147/OTT.S243215] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
370 Yang X, Suo C, Zhang T, Yin X, Man J, Yuan Z, Chen H, Yu J, Jin L, Chen X, Lu M, Ye W. A nomogram for screening esophageal squamous cell carcinoma based on environmental risk factors in a high-incidence area of China: a population-based case-control study. BMC Cancer 2021;21:343. [PMID: 33789604 DOI: 10.1186/s12885-021-08053-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
371 Li M, Yue C, Jin G, Guo H, Ma H, Wang G, Huang S, Wu F, Zhao X. Rs1884444 variant in IL23R gene is associated with a decreased risk in esophageal cancer in Chinese population. Mol Carcinog 2019;58:1822-31. [DOI: 10.1002/mc.23069] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
372 Wang S, Pan D, Su M, Huang G, Sun G. Moderately high folate level may offset the effects of aberrant DNA methylation of P16 and P53 genes in esophageal squamous cell carcinoma and precancerous lesions. Genes Nutr 2020;15:18. [PMID: 32993492 DOI: 10.1186/s12263-020-00677-x] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
373 Huang J, Koulaouzidis A, Marlicz W, Lok V, Chu C, Ngai CH, Zhang L, Chen P, Wang S, Yuan J, Lao XQ, Tse SLA, Xu W, Zheng ZJ, Xie SH, Wong MCS. Global Burden, Risk Factors, and Trends of Esophageal Cancer: An Analysis of Cancer Registries from 48 Countries. Cancers (Basel) 2021;13:E141. [PMID: 33466239 DOI: 10.3390/cancers13010141] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
374 Song X, Greiner-Tollersrud OK, Zhou H. Oral Microbiota Variation: A Risk Factor for Development and Poor Prognosis of Esophageal Cancer. Dig Dis Sci 2021. [PMID: 34505256 DOI: 10.1007/s10620-021-07245-2] [Reference Citation Analysis]
375 Liu Y, Wang L, Fang L, Liu H, Tian H, Zheng Y, Fan T, Li C, He J. A Multi-Center Validated Subtyping Model of Esophageal Cancer Based on Three Metabolism-Related Genes. Front Oncol 2021;11:772145. [PMID: 34760709 DOI: 10.3389/fonc.2021.772145] [Reference Citation Analysis]
376 Murakami T, Shoji Y, Nishi T, Chang SC, Jachimowicz RD, Hoshimoto S, Ono S, Shiloh Y, Takeuchi H, Kitagawa Y, Hoon DSB, Bustos MA. Regulation of MRE11A by UBQLN4 leads to cisplatin resistance in patients with esophageal squamous cell carcinoma. Mol Oncol 2021;15:1069-87. [PMID: 33605536 DOI: 10.1002/1878-0261.12929] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
377 Liu S, Lin Z, Huang L, Chen H, Liu Y, He F, Peng X, Chen W, Huang R, Lu W, Yang H, Xiang Z, Zhang Z, Hu Z. Oolong tea consumption and its interactions with a novel composite index on esophageal squamous cell carcinoma. BMC Complement Altern Med 2019;19:358. [PMID: 31822288 DOI: 10.1186/s12906-019-2770-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
378 Kato K, Cho BC, Takahashi M, Okada M, Lin CY, Chin K, Kadowaki S, Ahn MJ, Hamamoto Y, Doki Y, Yen CC, Kubota Y, Kim SB, Hsu CH, Holtved E, Xynos I, Kodani M, Kitagawa Y. Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol 2019;20:1506-17. [PMID: 31582355 DOI: 10.1016/S1470-2045(19)30626-6] [Cited by in Crossref: 205] [Cited by in F6Publishing: 127] [Article Influence: 68.3] [Reference Citation Analysis]
379 Feng Q, Zhang H, Yao D, Chen WD, Wang YD. Emerging Role of Non-Coding RNAs in Esophageal Squamous Cell Carcinoma. Int J Mol Sci. 2019;21. [PMID: 31905958 DOI: 10.3390/ijms21010258] [Cited by in Crossref: 12] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
380 Xin Z, Song X, Jiang B, Gongsun X, Song L, Qin Q, Wang Q, Shi M, Liu X. Blocking FGFR4 exerts distinct anti-tumorigenic effects in esophageal squamous cell carcinoma. Thorac Cancer 2018;9:1687-98. [PMID: 30267473 DOI: 10.1111/1759-7714.12883] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
381 Jiang Y, Zhang J, Zhao J, Li Z, Chen H, Qiao Y, Chen X, Liu K, Dong Z. TOPK promotes metastasis of esophageal squamous cell carcinoma by activating the Src/GSK3β/STAT3 signaling pathway via γ-catenin. BMC Cancer 2019;19:1264. [PMID: 31888532 DOI: 10.1186/s12885-019-6453-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
382 Zhang L. Novel stimulation strategy with autologous tumor cells to generate T cell receptor-engineered T cells in esophageal squamous cell carcinoma. Thorac Cancer 2020;11:1117-8. [PMID: 32189470 DOI: 10.1111/1759-7714.13404] [Reference Citation Analysis]
383 Su Z, Zou GR, Mao YP, OuYang PY, Cao XL, Xie FY, Li Q. Prognostic impact of family history of cancer in Southern Chinese patients with esophageal squamous cell cancer. J Cancer 2019;10:1349-57. [PMID: 31031844 DOI: 10.7150/jca.26511] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
384 Zhang X, Lu N, Wang L, Wang Y, Li M, Zhou Y, Cui M, Zhang M, Zhang L. Recent advances of m6A methylation modification in esophageal squamous cell carcinoma. Cancer Cell Int 2021;21:421. [PMID: 34376206 DOI: 10.1186/s12935-021-02132-2] [Reference Citation Analysis]
385 Wang SM, Katki HA, Graubard BI, Kahle LL, Chaturvedi A, Matthews CE, Freedman ND, Abnet CC. Population Attributable Risks of Subtypes of Esophageal and Gastric Cancers in the United States. Am J Gastroenterol 2021;116:1844-52. [PMID: 34240714 DOI: 10.14309/ajg.0000000000001355] [Reference Citation Analysis]
386 Yuan Q, Dong CD, Ge Y, Chen X, Li Z, Li X, Lu Q, Peng F, Wu X, Zhao J, Liu K. Proteome and phosphoproteome reveal mechanisms of action of atorvastatin against esophageal squamous cell carcinoma. Aging (Albany NY) 2019;11:9530-43. [PMID: 31697643 DOI: 10.18632/aging.102402] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
387 Ana Choi SS, Ko JM, Yu VZ, Ning L, Lung ML. Differentiation-related zinc finger protein 750 suppresses cell growth in esophageal squamous cell carcinoma. Oncol Lett 2021;22:513. [PMID: 33986873 DOI: 10.3892/ol.2021.12774] [Reference Citation Analysis]
388 Chen Y, Feng R, He B, Wang J, Xian N, Huang G, Zhang Q. PD-1H Expression Associated With CD68 Macrophage Marker Confers an Immune-Activated Microenvironment and Favorable Overall Survival in Human Esophageal Squamous Cell Carcinoma. Front Mol Biosci 2021;8:777370. [PMID: 34950702 DOI: 10.3389/fmolb.2021.777370] [Reference Citation Analysis]
389 Li Y, Zhu X, Yang M, Wang Y, Li J, Fang J, Guo W, Ma S, Guan F. YAP/TEAD4-induced KIF4A contributes to the progression and worse prognosis of esophageal squamous cell carcinoma. Mol Carcinog 2021;60:440-54. [PMID: 34003522 DOI: 10.1002/mc.23303] [Reference Citation Analysis]
390 Ding X, Qi C, Min J, Xu Z, Huang K, Tang H. Long non-coding RNA HEIH suppresses the expression of TP53 through enhancer of zeste homolog 2 in oesophageal squamous cell carcinoma. J Cell Mol Med 2020;24:10551-9. [PMID: 32729661 DOI: 10.1111/jcmm.15673] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
391 Xu YY, Wang WW, Huang J, Zhu WG. Ellagic acid induces esophageal squamous cell carcinoma cell apoptosis by modulating SHP-1/STAT3 signaling. Kaohsiung J Med Sci 2020;36:699-704. [PMID: 32374927 DOI: 10.1002/kjm2.12224] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
392 Wang Z, Zhang Q, Wu B. Development of an Empirically Calibrated Model of Esophageal Squamous Cell Carcinoma in High-Risk Regions. Biomed Res Int 2019;2019:2741598. [PMID: 31240208 DOI: 10.1155/2019/2741598] [Reference Citation Analysis]
393 Takahashi M, Kato K, Okada M, Chin K, Kadowaki S, Hamamoto Y, Doki Y, Kubota Y, Kawakami H, Ogata T, Hara H, Muto M, Nakashima Y, Ishihara R, Tsuda M, Motoyama S, Kodani M, Kitagawa Y. Nivolumab versus chemotherapy in Japanese patients with advanced esophageal squamous cell carcinoma: a subgroup analysis of a multicenter, randomized, open-label, phase 3 trial (ATTRACTION-3). Esophagus 2021;18:90-9. [PMID: 33170461 DOI: 10.1007/s10388-020-00794-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
394 Su Z, Gao A, Li X, Zou S, He C, Wu J, Ding WQ, Zhou J. DNA Polymerase Iota Promotes Esophageal Squamous Cell Carcinoma Proliferation Through Erk-OGT-Induced G6PD Overactivation. Front Oncol 2021;11:706337. [PMID: 34354953 DOI: 10.3389/fonc.2021.706337] [Reference Citation Analysis]
395 Tan Z, Li B, Dong X, Liu W, Liu S. The Role of β-Arrestin1 in Esophageal Squamous Cell Carcinoma. Onco Targets Ther 2020;13:1873-81. [PMID: 32184622 DOI: 10.2147/OTT.S235066] [Reference Citation Analysis]
396 Shimizu M, Koma YI, Sakamoto H, Tsukamoto S, Kitamura Y, Urakami S, Tanigawa K, Kodama T, Higashino N, Nishio M, Shigeoka M, Kakeji Y, Yokozaki H. Metallothionein 2A Expression in Cancer-Associated Fibroblasts and Cancer Cells Promotes Esophageal Squamous Cell Carcinoma Progression. Cancers (Basel) 2021;13:4552. [PMID: 34572779 DOI: 10.3390/cancers13184552] [Reference Citation Analysis]
397 Pidkovka N, Rachkevych O, Belkhiri A. Extrahepatic cytochrome P450 epoxygenases: pathophysiology and clinical significance in human gastrointestinal cancers. Oncotarget 2021;12:379-91. [PMID: 33659048 DOI: 10.18632/oncotarget.27893] [Reference Citation Analysis]
398 Guo W, Tan F, Huai Q, Wang Z, Shao F, Zhang G, Yang Z, Li R, Xue Q, Gao S, He J. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma. Front Immunol 2021;12:669750. [PMID: 34054840 DOI: 10.3389/fimmu.2021.669750] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
399 Kayamba V. Oesophageal cancer hotspots in Africa. Lancet Gastroenterol Hepatol 2019;4:818-20. [PMID: 31609235 DOI: 10.1016/S2468-1253(19)30253-5] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
400 Yao W, Wang J, Meng F, Zhu Z, Jia X, Xu L, Zhang Q, Wei L. Circular RNA CircPVT1 Inhibits 5-Fluorouracil Chemosensitivity by Regulating Ferroptosis Through MiR-30a-5p/FZD3 Axis in Esophageal Cancer Cells. Front Oncol 2021;11:780938. [PMID: 34966683 DOI: 10.3389/fonc.2021.780938] [Reference Citation Analysis]
401 Wu M, Wang Y, Yang D, Gong Y, Rao F, Liu R, Danna Y, Li J, Fan J, Chen J, Zhang W, Zhan Q. A PLK1 kinase inhibitor enhances the chemosensitivity of cisplatin by inducing pyroptosis in oesophageal squamous cell carcinoma. EBioMedicine 2019;41:244-55. [PMID: 30876762 DOI: 10.1016/j.ebiom.2019.02.012] [Cited by in Crossref: 37] [Cited by in F6Publishing: 48] [Article Influence: 12.3] [Reference Citation Analysis]
402 Yan J, Shi L, Lin S, Li Y. MicroRNA-624-mediated ARRDC3/YAP/HIF1α axis enhances esophageal squamous cell carcinoma cell resistance to cisplatin and paclitaxel. Bioengineered 2021;12:5334-47. [PMID: 34415232 DOI: 10.1080/21655979.2021.1938497] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
403 Shao D, Vogtmann E, Liu A, Qin J, Chen W, Abnet CC, Wei W. Microbial characterization of esophageal squamous cell carcinoma and gastric cardia adenocarcinoma from a high-risk region of China. Cancer 2019;125:3993-4002. [PMID: 31355925 DOI: 10.1002/cncr.32403] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
404 Pan P, Dombkowski AA, Wang LS, Stoner GD. A nutrigenetic approach for investigating the chemopreventive effects of black raspberries during the development of preneoplastic esophagi in rats. J Berry Res 2018;8:263-74. [PMID: 30613310 DOI: 10.3233/JBR-180346] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
405 Yang Y, Jia J, Sun Z, Liu C, Li Z, Xiao Y, Yu J, Du F, Shi Y, Sun J, Shui J, Zhang X. Polymorphism of FGD4 and myelosuppression in patients with esophageal squamous cell carcinoma. Future Oncol 2021;17:2351-63. [PMID: 33709789 DOI: 10.2217/fon-2020-1191] [Reference Citation Analysis]
406 Chen W, Li H, Ren J, Zheng R, Shi J, Li J, Cao M, Sun D, He S, Sun X, Cao X, Feng S, Zhou J, Luo P, Zha Z, Jia S, Wang J, Ma H, Zeng H, Canfell K, He J. Selection of high-risk individuals for esophageal cancer screening: A prediction model of esophageal squamous cell carcinoma based on a multicenter screening cohort in rural China. Int J Cancer 2021;148:329-39. [PMID: 32663318 DOI: 10.1002/ijc.33208] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
407 Li J, Ko JM, Dai W, Yu VZ, Ng HY, Hoffmann JS, Lung ML. Depletion of DNA Polymerase Theta Inhibits Tumor Growth and Promotes Genome Instability through the cGAS-STING-ISG Pathway in Esophageal Squamous Cell Carcinoma. Cancers (Basel) 2021;13:3204. [PMID: 34206946 DOI: 10.3390/cancers13133204] [Reference Citation Analysis]
408 Ishida H, Kasajima A, Fujishima F, Akaishi R, Ueki S, Yamazaki Y, Onodera Y, Gao X, Okamoto H, Taniyama Y, Kamei T, Sasano H. p16 in highly malignant esophageal carcinomas: the correlation with clinicopathological factors and human papillomavirus infection. Virchows Arch 2021;478:219-29. [PMID: 32556556 DOI: 10.1007/s00428-020-02865-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
409 Peng C, Cohen DJ. Advances in the pharmacotherapeutic management of esophageal squamous cell carcinoma. Expert Opin Pharmacother 2021;22:93-107. [PMID: 33034212 DOI: 10.1080/14656566.2020.1813278] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
410 Liu L, Liu X, Sun Y, Zeng Y, Tang X, Li X, Liu J, Xiao R. Esophageal squamous cell cancer coincides with myelodysplastic syndrome/acute myelogenous leukemia: A case report and review of the literature. Oncol Lett 2020;20:266. [PMID: 32989400 DOI: 10.3892/ol.2020.12129] [Reference Citation Analysis]
411 Xiong Z, Wu J, Sun Y, Bai M, Niu F, Jin T. Variants in multiple genes are associated with esophageal cancer risk in a Chinese Han population: A case-control study. J Gene Med 2020;22:e3266. [PMID: 32864859 DOI: 10.1002/jgm.3266] [Reference Citation Analysis]
412 Yang CS, Chen XL. Research on esophageal cancer: With personal perspectives from studies in China and Kenya. Int J Cancer 2021;149:264-76. [PMID: 33270917 DOI: 10.1002/ijc.33421] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
413 Duan Q, Tang C, Ma Z, Chen C, Shang X, Yue J, Jiang H, Gao Y, Xu B. Genomic Heterogeneity and Clonal Evolution in Gastroesophageal Junction Cancer Revealed by Single Cell DNA Sequencing. Front Oncol 2021;11:672020. [PMID: 34046362 DOI: 10.3389/fonc.2021.672020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
414 Li W, Liu J, Zhao H. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma. Aging (Albany NY) 2020;12:1512-26. [PMID: 31978896 DOI: 10.18632/aging.102697] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
415 Brown J, Stepien AJ, Willem P. Landscape of copy number aberrations in esophageal squamous cell carcinoma from a high endemic region of South Africa. BMC Cancer 2020;20:281. [PMID: 32252688 DOI: 10.1186/s12885-020-06788-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]